<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group>
<journal-title>PLoS ONE</journal-title></journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, USA</publisher-loc></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PONE-D-14-04608</article-id>
<article-id pub-id-type="doi">10.1371/journal.pone.0101533</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biology and life sciences</subject><subj-group><subject>Nutrition</subject><subj-group><subject>Nutrients</subject><subj-group><subject>Vitamins</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine and health sciences</subject><subj-group><subject>Complementary and alternative medicine</subject></subj-group><subj-group><subject>Health care</subject><subj-group><subject>Communication in health care</subject><subject>Health care policy</subject><subject>Health education and awareness</subject><subject>Medical communications</subject></subj-group></subj-group><subj-group><subject>Public and occupational health</subject><subj-group><subject>Behavioral and social aspects of health</subject></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Press Releases Issued by Supplements Industry Organisations and Non-Industry Organisations in Response to Publication of Clinical Research Findings: A Case-Control Study</article-title>
<alt-title alt-title-type="running-head">Clinical Research Findings and Press Releases</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Wang</surname><given-names>Michael T. M.</given-names></name><xref ref-type="aff" rid="aff1"/></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Gamble</surname><given-names>Greg</given-names></name><xref ref-type="aff" rid="aff1"/></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Bolland</surname><given-names>Mark J.</given-names></name><xref ref-type="aff" rid="aff1"/></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Grey</surname><given-names>Andrew</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib>
</contrib-group>
<aff id="aff1"><addr-line>Department of Medicine, University of Auckland, Auckland, New Zealand</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple"><name name-style="western"><surname>Gluud</surname><given-names>Christian</given-names></name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/></contrib>
</contrib-group>
<aff id="edit1"><addr-line>Copenhagen University Hospital, Denmark</addr-line></aff>
<author-notes>
<corresp id="cor1">* E-mail: <email xlink:type="simple">a.grey@auckland.ac.nz</email></corresp>
<fn fn-type="conflict"><p>The authors have declared that no competing interests exist.</p></fn>
<fn fn-type="con"><p>Conceived and designed the experiments: MW GG MB AG. Performed the experiments: MW AG. Analyzed the data: MW GG. Wrote the paper: MW GG MB AG.</p></fn>
</author-notes>
<pub-date pub-type="collection"><year>2014</year></pub-date>
<pub-date pub-type="epub"><day>3</day><month>7</month><year>2014</year></pub-date>
<volume>9</volume>
<issue>7</issue>
<elocation-id>e101533</elocation-id>
<history>
<date date-type="received"><day>30</day><month>1</month><year>2014</year></date>
<date date-type="accepted"><day>9</day><month>6</month><year>2014</year></date>
</history>
<permissions>
<copyright-year>2014</copyright-year>
<copyright-holder>Wang et al</copyright-holder><license xlink:type="simple"><license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions>
<abstract><sec>
<title>Background</title>
<p>Dietary supplement use is increasing despite lack of evidence of benefits, or evidence of harm. Press releases issued by the supplements industry might contribute to this situation by using ‘spin’ (strategies to hype or denigrate findings) to distort the results of clinical studies. We assessed press releases issued in response to publication of clinical studies on dietary supplements.</p>
</sec><sec>
<title>Methods and Findings</title>
<p>We analyzed 47 supplements industry press releases and 91 non-industry press releases and news stories, generated in response to 46 clinical studies of dietary supplements published between 1/1/2005 and 5/31/2013. The primary outcome was ‘spin’ content and direction. We also assessed disposition towards use of dietary supplements, reporting of study information, and dissemination of industry press releases. More supplements industry press releases (100%) contained ‘spin’ than non-industry media documents (55%, P&lt;0.001). Hyping ‘spin’ scores were higher in industry than non-industry media documents for studies reporting benefit of supplements (median ‘spin’ score 3.3, 95% CI 1.0–5.5 vs 0.5, 0–1.0; P&lt;0.001). Denigratory ‘spin’ scores were higher in industry than non-industry media documents for studies reporting no effect (6.0, 5.0–7.0 vs 0, 0–0; P&lt;0.001) or harm (6.0, 5.5–7.5 vs 0, 0–0.5; P&lt;0.001) from a supplement. Industry press releases advocated supplement use in response to &gt;90% of studies that reported no benefit, or harm, of the supplement. Industry press releases less frequently reported study outcomes, sample size, and estimates of effect size than non-industry media documents (all P&lt;0.001), particularly for studies that reported no benefit of supplements. Industry press releases were referenced by 148 news stories on the websites of 6 organizations that inform manufacturers, retailers and consumers of supplements.</p>
</sec><sec>
<title>Conclusions</title>
<p>Dietary supplements industry press releases issued in response to clinical research findings are characterized by ‘spin’ that hypes results that are favourable to supplement use and denigrates results that are not.</p>
</sec></abstract>
<funding-group><funding-statement>Michael Wang is the recipient of a University of Auckland summer studentship to conduct this work. Mark Bolland is the recipient of a Hercus Fellowship from the Health Research Council of New Zealand (<ext-link ext-link-type="uri" xlink:href="http://www.hrc.govt.nz/" xlink:type="simple">http://www.hrc.govt.nz/</ext-link>). Neither funder had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><page-count count="14"/></counts></article-meta>
</front>
<body><sec id="s1">
<title>Introduction</title>
<p>About half of US adults, and two-thirds of those&gt;60 years, take dietary supplements <xref ref-type="bibr" rid="pone.0101533-Bailey1">[1]</xref>. Similar data have been reported outside of the USA <xref ref-type="bibr" rid="pone.0101533-Bacon1">[2]</xref>, <xref ref-type="bibr" rid="pone.0101533-Denison1">[3]</xref>. The supplements industry is profitable: Americans spend more than US$30 billion annually on dietary supplements <xref ref-type="bibr" rid="pone.0101533-Bailey1">[1]</xref>. Motivations to take dietary supplements are diverse, but users most commonly cite a wish to improve or maintain health <xref ref-type="bibr" rid="pone.0101533-Bailey1">[1]</xref>, <xref ref-type="bibr" rid="pone.0101533-Blendon1">[4]</xref>. The sources of information which influence decisions to use dietary supplements are also multiple. Only 23% of US adults who take supplements do so on the advice of a health care professional <xref ref-type="bibr" rid="pone.0101533-Bailey1">[1]</xref>. In healthy older adults, important sources of information that influence decisions about supplement use include magazines, news articles, and people other than health professionals <xref ref-type="bibr" rid="pone.0101533-Bacon1">[2]</xref>, <xref ref-type="bibr" rid="pone.0101533-Albertazzi1">[5]</xref>.</p>
<p>In the past decade, there has been intensive investigation of the health benefits and risks of dietary supplements. Consequently, there have been many publications in prominent medical journals on dietary supplements; these often reported no benefit and sometimes reported harm <xref ref-type="bibr" rid="pone.0101533-Bailey1">[1]</xref>, <xref ref-type="bibr" rid="pone.0101533-Bjelakovic1">[6]</xref>–<xref ref-type="bibr" rid="pone.0101533-Klein1">[8]</xref>. Publications of randomized clinical trial data showing no health benefit of omega-3 fatty acids had no discernible effect on the contemporaneous progressive increase in use of the supplements <xref ref-type="bibr" rid="pone.0101533-Grey1">[9]</xref>. The reason(s) for the burgeoning use of dietary supplements despite accrual of rigorous evidence of no benefit or harm is uncertain, but a survey of supplement users reported that only 25% of users would alter their behaviour in response to findings of clinical studies that contradicted the health claims made by supplements manufacturers <xref ref-type="bibr" rid="pone.0101533-Blendon1">[4]</xref>.</p>
<p>Organizations that represent the commercial interests of supplements manufacturers take an interest in the outcomes of clinical research on dietary supplements. A means by which organizations with commercial interests might influence the responses of supplements users to the outcomes of clinical research is via press releases that generate news stories in media accessed by marketers and consumers of supplements. To investigate this possibility, we analyzed the tone, content, conclusions, and propagation of press releases generated by prominent organizations representing the dietary supplements industry in response to the publication of clinical research about supplements. We also compared the industry press releases to contemporaneous non-industry press releases or news stories.</p>
</sec><sec id="s2" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="s2a">
<title>Study Documents</title>
<p>Between 5/31/13 and 6/15/13, we extracted from 3 industry websites (the Council for Responsible Nutrition, CRN, “the leading trade association representing dietary supplement manufacturers and ingredient suppliers”, <ext-link ext-link-type="uri" xlink:href="http://www.crnusa.org" xlink:type="simple">http://www.crnusa.org</ext-link>, the Alliance for Natural Health,ANH, “a non-governmental organisation promoting natural and sustainable approaches to healthcare worldwide”, <ext-link ext-link-type="uri" xlink:href="http://www.anh-usa.org" xlink:type="simple">http://www.anh-usa.org</ext-link>, and the Natural Products Association,NPA, “the leading representative of the dietary supplement industry”, <ext-link ext-link-type="uri" xlink:href="http://www.npainfo.org" xlink:type="simple">http://www.npainfo.org</ext-link>) press releases issued in response to clinical studies of dietary supplements published between 1/1/05 and 5/31/13. We defined a clinical study as one that assessed the effects on human health of a dietary supplement or its food-based equivalent.</p>
<p>For each publication that generated a press release from an industry source, we collated two press releases or news stories from non-industry sources, using a structured approach. First, we extracted press releases from the National Institutes Health (NIH)/National Center for Complementary and Alternative Medicine (NCCAM), by searching its website and the EurekAlert! database (<ext-link ext-link-type="uri" xlink:href="http://www.eurekalert.org" xlink:type="simple">http://www.eurekalert.org</ext-link>). Next, we collated press releases issued by the journals that published the source articles, by searching the journal websites and the EurekAlert! database. Lastly, we accessed news stories from news agencies, identified by a Google search using search terms that included the name of the supplement, the primary author of the source article, and the journal of publication, with a time limit of two months from the date of publication. We extracted the first 1–2 news stories that were identified by our search. If a press release referred to more than one source publication, it was analysed for each publication. If fewer than two corresponding non-industry media documents were identified, the industry press release was excluded from further analysis.</p>
<p>The publications that stimulated the press releases from industry sources were collated using PubMed.</p>
<p><xref ref-type="fig" rid="pone-0101533-g001">Figure 1</xref> summarizes the collation of study documents.</p>
<fig id="pone-0101533-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0101533.g001</object-id><label>Figure 1</label><caption>
<title>Collation of study documents.</title>
<p>CRN, Council for Responsible Nutrition; NPA, Natural Products Association; ANH, Alliance for Natural Health.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0101533.g001" position="float" xlink:type="simple"/></fig></sec><sec id="s2b">
<title>Data Abstraction</title>
<p>Data were abstracted independently by two reviewers (MW and AG). For data that involved some subjectivity, such as the presence, type, and direction of ‘spin’, the interpretation of the title and text of the media documents and the ‘spin’ score, differences were resolved by consensus.</p>
<sec id="s2b1">
<title>Source Publications</title>
<p>We adapted a data abstraction tool that evaluated the quality of reporting of clinical research <xref ref-type="bibr" rid="pone.0101533-Yavchitz1">[10]</xref>, <xref ref-type="bibr" rid="pone.0101533-Schwartz1">[11]</xref> (<xref ref-type="supplementary-material" rid="pone.0101533.s004">Text S1</xref>). Study conclusions were categorized as favours supplement use; does not favour supplement use - no effect; or does not favour supplement use - harm. If the source publication reported more than one outcome and the effects of the intervention were mixed, the assignation of study conclusion was to the category of the predominant effect or, if either benefit or harm was reported in combination with no effect, to favours supplement use or does not favour supplement use - harm, respectively.</p>
</sec><sec id="s2b2">
<title>Press Releases</title>
<p>From the press releases and news stories, data were extracted on reporting of study characteristics (<xref ref-type="supplementary-material" rid="pone.0101533.s005">Text S2</xref>). Quotes from industry staff, independent experts, and study investigators were collated. The title and text of each media document were assessed as to whether they supported use of the supplement, did not support use of the supplement, or were neutral <xref ref-type="bibr" rid="pone.0101533-Yavchitz1">[10]</xref>. If one reviewer considered a document to be neutral towards supplement use and the other reviewer considered it to be either supportive or not supportive of supplement use, the document was scored as supporting or not supporting use, respectively.</p>
</sec><sec id="s2b3">
<title>‘Spin’ assessment</title>
<p>Each press release or news story was assessed for the presence and amount of ‘spin’ considered to be either hyping of, or denigratory towards, the source publication, using a standardized format (<xref ref-type="supplementary-material" rid="pone.0101533.s006">Text S3</xref>). Hyping ‘spin’ is specific reporting that unduly emphasizes or exaggerates the benefit of an experimental treatment <xref ref-type="bibr" rid="pone.0101533-Boutron1">[12]</xref>. We defined denigratory ‘spin’ as specific reporting that unduly downplays or dismisses the lack of benefit, or harm, caused by an experimental treatment. To assess hyping ‘spin’ we adapted published methods which included a checklist of ‘spin’ strategies <xref ref-type="bibr" rid="pone.0101533-Yavchitz1">[10]</xref>, <xref ref-type="bibr" rid="pone.0101533-Woloshin1">[13]</xref>. To assess denigratory ‘spin’ we designed a data abstraction form by adapting that used for assessment of hyping ‘spin’ and incorporating into the checklist commonly employed denigratory strategies identified from a review of relevant literature <xref ref-type="bibr" rid="pone.0101533-Prasad1">[14]</xref>, <xref ref-type="bibr" rid="pone.0101533-Tatsioni1">[15]</xref> and media and academic responses to publication of clinical research.</p>
<p>Each press release and news story in the study sample set was independently assessed by two reviewers (MW and AG). If a document was considered to either hype or denigrate the clinical research, the assessor proceeded to complete a checklist of ‘spin’ techniques (<xref ref-type="supplementary-material" rid="pone.0101533.s006">Text S3</xref>). To produce a score for each form of ‘spin’, we assigned one point to each checklist item identified in a press release or news story. Summing the hyping and denigratory ‘spin’ scores produced a total ‘spin’ score. Discrepancies in the total ‘spin’ score of &gt;2 points between reviewers were resolved by consensus. If the difference between the reviewers’ scores was≤2 points, the mean value of the scores was included in the analysis. The inter-observer agreement for the ‘spin’ score was assessed in a sample of 10 press releases and news stories (5 industry and 5 non-industry) that were independent from the final study sample, being issued prior to 1 January 2005. In this analysis, the kappa coefficient was 0.64 (95% CI 0.59–0.84). The kappa coefficient is the proportion of agreement between two assessors, adjusted for chance agreement <xref ref-type="bibr" rid="pone.0101533-deVet1">[16]</xref>. Values within the range 0.61–0.80 indicate substantial agreement <xref ref-type="bibr" rid="pone.0101533-Landis1">[17]</xref>.</p>
</sec></sec><sec id="s2c">
<title>Industry press release propagation</title>
<p>To assess the potential impact of the industry press releases, we sought news reports that referenced them. We searched the websites of six organizations (NewHope360, <ext-link ext-link-type="uri" xlink:href="http://newhope360.com/" xlink:type="simple">http://newhope360.com/</ext-link>; Nutritional Outlook, <ext-link ext-link-type="uri" xlink:href="http://www.nutritionaloutlook.com/" xlink:type="simple">http://www.nutritionaloutlook.com/</ext-link>; Natural Products Insider, <ext-link ext-link-type="uri" xlink:href="http://www.naturalproductsinsider.com/" xlink:type="simple">http://www.naturalproductsinsider.com/</ext-link>; Drug Store News, <ext-link ext-link-type="uri" xlink:href="http://drugstorenews.com/" xlink:type="simple">http://drugstorenews.com/</ext-link>; Nutraceuticals World, <ext-link ext-link-type="uri" xlink:href="http://www.nutraceuticalsworld.com" xlink:type="simple">http://www.nutraceuticalsworld.com</ext-link>; Whole Food Magazine, <ext-link ext-link-type="uri" xlink:href="http://www.wholefoodsmagazine.com/" xlink:type="simple">http://www.wholefoodsmagazine.com/</ext-link>) that provide information and advice to manufacturers, marketers and retailers of dietary supplements, using search terms that included the sources of the industry press releases and each of the interventions studied in the source publications. From each site, we collated all news stories that directly referenced, or contained verbatim material from, any of the industry press releases in our sample set.</p>
</sec><sec id="s2d">
<title>Statistics</title>
<p>The sample size of industry press releases was pragmatically determined by the number issued during the study period. Analyses were performed using Graph Pad Prism version 6.02 (<ext-link ext-link-type="uri" xlink:href="http://www.graphpad.com" xlink:type="simple">http://www.graphpad.com</ext-link>). Between-group comparisons of continuous variables were made using Wilcoxon rank sum text. Analyses of categorical data were performed using Fisher’s exact test test or chi-squared test, as appropriate. Confidence intervals about medians were calculated using Graph Pad Prism version 6.02 and about percentages using Open Source Epidemiologic Statistics for Public Health (<ext-link ext-link-type="uri" xlink:href="http://www.openepi.com" xlink:type="simple">http://www.openepi.com</ext-link>), accessed November 2013. Since all comparisons were pre-planned no adjustment for multiplicity was performed. All tests were two tailed and P&lt;0.05 was considered significant. Data are presented as median (95% CI) unless otherwise stated.</p>
</sec></sec><sec id="s3">
<title>Results</title>
<sec id="s3a">
<title>Industry press releases and source publications</title>
<p>The final dataset contained 47 industry press releases (39 from the Council for Responsible Nutrition (CRN),; 3 from the Natural Products Association (NPA); 5 from the Alliance for Natural Health (ANH)). Some industry press releases referred to more than one source article, and some source articles generated press releases from more than one industry source. Consequently, the 47 industry press releases contained 53 responses to 46 source publications <xref ref-type="bibr" rid="pone.0101533-Lee1">[18]</xref>–<xref ref-type="bibr" rid="pone.0101533-Xiao1">[63]</xref> (<xref ref-type="table" rid="pone-0101533-t001">Table 1</xref>). Thirty-eight (83%) of the source articles were published in the seven most prestigious internal medicine journals, as judged by impact factor. The median (range) impact factor of the journals in which the source articles were published was 11 (4–51). Thirty-nine (85%) studies reported “hard” disease outcomes.</p>
<table-wrap id="pone-0101533-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0101533.t001</object-id><label>Table 1</label><caption>
<title>Press releases, news stories and source publications.</title>
</caption><alternatives><graphic id="pone-0101533-t001-1" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0101533.t001" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td colspan="2" align="left" rowspan="1">Sources of Press Releases and News Stories</td>
<td align="left" rowspan="1" colspan="1">Source Article</td>
<td align="left" rowspan="1" colspan="1">Study Design</td>
<td align="left" rowspan="1" colspan="1">N</td>
<td align="left" rowspan="1" colspan="1">Intervention/Exposure</td>
<td align="left" rowspan="1" colspan="1">Reported Outcome Measure(s)</td>
<td align="left" rowspan="1" colspan="1">Results</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Industry</td>
<td align="left" rowspan="1" colspan="1">Non-industry</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">CRN</td>
<td align="left" rowspan="1" colspan="1">NHLBI, JAMA</td>
<td align="left" rowspan="1" colspan="1">Lee 2005 <xref ref-type="bibr" rid="pone.0101533-Lee1">[18]</xref></td>
<td align="left" rowspan="1" colspan="1">RCT</td>
<td align="left" rowspan="1" colspan="1">39876</td>
<td align="left" rowspan="1" colspan="1">Vitamin E</td>
<td align="left" rowspan="1" colspan="1">First majorCV event</td>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Total invasivecancer</td>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">CRN</td>
<td align="left" rowspan="1" colspan="1">JAMA, CBC</td>
<td align="left" rowspan="1" colspan="1">Lonn 2005 <xref ref-type="bibr" rid="pone.0101533-Lonn1">[19]</xref></td>
<td align="left" rowspan="1" colspan="1">RCT</td>
<td align="left" rowspan="1" colspan="1">9541</td>
<td align="left" rowspan="1" colspan="1">Vitamin E</td>
<td align="left" rowspan="1" colspan="1">Cancer incidence</td>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Cancer mortality</td>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Major CV events</td>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">CRN</td>
<td align="left" rowspan="1" colspan="1">BBC, NY Times</td>
<td align="left" rowspan="1" colspan="1">Miller 2005 <xref ref-type="bibr" rid="pone.0101533-Miller1">[20]</xref></td>
<td align="left" rowspan="1" colspan="1">Meta-RCT</td>
<td align="left" rowspan="1" colspan="1">135967</td>
<td align="left" rowspan="1" colspan="1">Vitamin E</td>
<td align="left" rowspan="1" colspan="1">All-cause mortality</td>
<td align="left" rowspan="1" colspan="1">Harm</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">CRN</td>
<td align="left" rowspan="1" colspan="1">NY Times, SF Chronicle</td>
<td align="left" rowspan="1" colspan="1">Bent 2006 <xref ref-type="bibr" rid="pone.0101533-Bent1">[21]</xref></td>
<td align="left" rowspan="1" colspan="1">RCT</td>
<td align="left" rowspan="1" colspan="1">225</td>
<td align="left" rowspan="1" colspan="1">Saw palmetto</td>
<td align="left" rowspan="1" colspan="1">Urologicalsymptoms</td>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Urinary flowrate</td>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">CRN</td>
<td align="left" rowspan="1" colspan="1">Health Day, NY Times</td>
<td align="left" rowspan="1" colspan="1">Bonaa 2006 <xref ref-type="bibr" rid="pone.0101533-Bonaa1">[22]</xref></td>
<td align="left" rowspan="1" colspan="1">RCT</td>
<td align="left" rowspan="1" colspan="1">3749</td>
<td align="left" rowspan="1" colspan="1">Folic acid + Vitamin B<sub>12</sub>+ Vitamin B<sub>6</sub></td>
<td align="left" rowspan="1" colspan="1">CV disease</td>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Folic acid + Vitamin B<sub>12</sub></td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Vitamin B<sub>6</sub></td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">CRN</td>
<td align="left" rowspan="1" colspan="1">NCCAM, NY Times</td>
<td align="left" rowspan="1" colspan="1">Clegg 2006 <xref ref-type="bibr" rid="pone.0101533-Clegg1">[23]</xref></td>
<td align="left" rowspan="1" colspan="1">RCT</td>
<td align="left" rowspan="1" colspan="1">1583</td>
<td align="left" rowspan="1" colspan="1">Chondroitin</td>
<td align="left" rowspan="1" colspan="1">Knee pain</td>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Glucosamine</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Chondroitin + glucosamine</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">CRN</td>
<td align="left" rowspan="1" colspan="1">NHLBI, NY Times</td>
<td align="left" rowspan="1" colspan="1">Jackson 2006 <xref ref-type="bibr" rid="pone.0101533-Jackson1">[24]</xref></td>
<td align="left" rowspan="1" colspan="1">RCT</td>
<td align="left" rowspan="1" colspan="1">36282</td>
<td align="left" rowspan="1" colspan="1">Calcium + Vitamin D</td>
<td align="left" rowspan="1" colspan="1">Hip fracture</td>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Spine fracture</td>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Total fracture</td>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">CRN</td>
<td align="left" rowspan="1" colspan="1">NY Times, Washington Post</td>
<td align="left" rowspan="1" colspan="1">Lonn 2006 <xref ref-type="bibr" rid="pone.0101533-Lonn2">[25]</xref></td>
<td align="left" rowspan="1" colspan="1">RCT</td>
<td align="left" rowspan="1" colspan="1">5522</td>
<td align="left" rowspan="1" colspan="1">Folic acid + Vitamin B<sub>6</sub>+ Vitamin B<sub>12</sub></td>
<td align="left" rowspan="1" colspan="1">Mortality fromCV causes,myocardialinfarction orstroke</td>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">CRN</td>
<td align="left" rowspan="1" colspan="1">JAMA, Wall Street Journal</td>
<td align="left" rowspan="1" colspan="1">Prince 2006 <xref ref-type="bibr" rid="pone.0101533-Prince1">[26]</xref></td>
<td align="left" rowspan="1" colspan="1">RCT</td>
<td align="left" rowspan="1" colspan="1">1460</td>
<td align="left" rowspan="1" colspan="1">Calcium</td>
<td align="left" rowspan="1" colspan="1">Osteoporoticfractures</td>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Vertebraldeformity</td>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">CRN</td>
<td align="left" rowspan="1" colspan="1">NHLBI, NY Times</td>
<td align="left" rowspan="1" colspan="1">Wactawski-Wende 2006 <xref ref-type="bibr" rid="pone.0101533-WactawskiWende1">[27]</xref></td>
<td align="left" rowspan="1" colspan="1">RCT</td>
<td align="left" rowspan="1" colspan="1">36282</td>
<td align="left" rowspan="1" colspan="1">Calcium + Vitamin D</td>
<td align="left" rowspan="1" colspan="1">Colorectalcancer<xref ref-type="table-fn" rid="nt103">i</xref></td>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">CRN</td>
<td align="left" rowspan="1" colspan="1">JAMA, AP</td>
<td align="left" rowspan="1" colspan="1">Bjelakovic 2007 <xref ref-type="bibr" rid="pone.0101533-Bjelakovic2">[28]</xref></td>
<td align="left" rowspan="1" colspan="1">Meta-RCT</td>
<td align="left" rowspan="1" colspan="1">232606</td>
<td align="left" rowspan="1" colspan="1">Beta carotene</td>
<td align="left" rowspan="1" colspan="1">All-cause mortality</td>
<td align="left" rowspan="1" colspan="1">Harm</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Vitamin A</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Harm</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Vitamin C</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Vitamin E</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Harm</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Selenium</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">CRN</td>
<td align="left" rowspan="1" colspan="1">JAMA, AP</td>
<td align="left" rowspan="1" colspan="1">Cole 2007 <xref ref-type="bibr" rid="pone.0101533-Cole1">[29]</xref></td>
<td align="left" rowspan="1" colspan="1">RCT</td>
<td align="left" rowspan="1" colspan="1">1021</td>
<td align="left" rowspan="1" colspan="1">Folic acid</td>
<td align="left" rowspan="1" colspan="1">Colorectaladenoma</td>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">CRN</td>
<td align="left" rowspan="1" colspan="1">National Post, US News</td>
<td align="left" rowspan="1" colspan="1">Lappe 2007 <xref ref-type="bibr" rid="pone.0101533-Lappe1">[30]</xref></td>
<td align="left" rowspan="1" colspan="1">RCT</td>
<td align="left" rowspan="1" colspan="1">1179</td>
<td align="left" rowspan="1" colspan="1">Calcium</td>
<td align="left" rowspan="1" colspan="1">Cancer<xref ref-type="table-fn" rid="nt103">i</xref></td>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Calcium + Vitamin D</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Benefit</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">CRN</td>
<td align="left" rowspan="1" colspan="1">JAMA, NY Times</td>
<td align="left" rowspan="1" colspan="1">Lin 2007 <xref ref-type="bibr" rid="pone.0101533-Lin1">[31]</xref></td>
<td align="left" rowspan="1" colspan="1">Prospective Cohort</td>
<td align="left" rowspan="1" colspan="1">31487</td>
<td align="left" rowspan="1" colspan="1">Calcium + Vitamin D</td>
<td align="left" rowspan="1" colspan="1">Breast Cancer</td>
<td align="left" rowspan="1" colspan="1">Benefit</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">CRN</td>
<td align="left" rowspan="1" colspan="1">NY Times, US News</td>
<td align="left" rowspan="1" colspan="1">Reichenbach 2007 <xref ref-type="bibr" rid="pone.0101533-Reichenbach1">[32]</xref></td>
<td align="left" rowspan="1" colspan="1">Meta-RCT</td>
<td align="left" rowspan="1" colspan="1">3846</td>
<td align="left" rowspan="1" colspan="1">Chondroitin</td>
<td align="left" rowspan="1" colspan="1">Joint pain</td>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">CRN</td>
<td align="left" rowspan="1" colspan="1">BBC, NY Times</td>
<td align="left" rowspan="1" colspan="1">Shah 2007 <xref ref-type="bibr" rid="pone.0101533-Shah1">[33]</xref></td>
<td align="left" rowspan="1" colspan="1">Meta-RCT</td>
<td align="left" rowspan="1" colspan="1">1356</td>
<td align="left" rowspan="1" colspan="1">Echinacea</td>
<td align="left" rowspan="1" colspan="1">Incidence ofcommon cold</td>
<td align="left" rowspan="1" colspan="1">Benefit</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">1630</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Duration ofcommon cold</td>
<td align="left" rowspan="1" colspan="1">Benefit</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">CRN, ANH</td>
<td align="left" rowspan="1" colspan="1">Cochrane, ABC</td>
<td align="left" rowspan="1" colspan="1">Bjelakovic 2008 <xref ref-type="bibr" rid="pone.0101533-Bjelakovic3">[34]</xref></td>
<td align="left" rowspan="1" colspan="1">Meta-RCT</td>
<td align="left" rowspan="1" colspan="1">232550</td>
<td align="left" rowspan="1" colspan="1">Beta-carotene</td>
<td align="left" rowspan="1" colspan="1">Mortality</td>
<td align="left" rowspan="1" colspan="1">Harm</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Vitamin A</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Harm</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Vitamin C</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Vitamin E</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Harm</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Selenium</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">CRN</td>
<td align="left" rowspan="1" colspan="1">NCCAM, USA Today</td>
<td align="left" rowspan="1" colspan="1">Sawitzke 2008 <xref ref-type="bibr" rid="pone.0101533-Sawitzke1">[35]</xref></td>
<td align="left" rowspan="1" colspan="1">RCT</td>
<td align="left" rowspan="1" colspan="1">572</td>
<td align="left" rowspan="1" colspan="1">Glucosamine</td>
<td align="left" rowspan="1" colspan="1">Joint spacewidth</td>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Chondroitin</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Glucosamine + Chondroitin</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">CRN</td>
<td align="left" rowspan="1" colspan="1">JAMA, Reuters</td>
<td align="left" rowspan="1" colspan="1">Sesso 2008 <xref ref-type="bibr" rid="pone.0101533-Sesso1">[36]</xref></td>
<td align="left" rowspan="1" colspan="1">RCT</td>
<td align="left" rowspan="1" colspan="1">14641</td>
<td align="left" rowspan="1" colspan="1">Vitamin E</td>
<td align="left" rowspan="1" colspan="1">Major CVevents</td>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Vitamin C</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">CRN, ANH</td>
<td align="left" rowspan="1" colspan="1">JAMA, Bloomberg</td>
<td align="left" rowspan="1" colspan="1">Christen 2009 <xref ref-type="bibr" rid="pone.0101533-Christen1">[37]</xref></td>
<td align="left" rowspan="1" colspan="1">RCT</td>
<td align="left" rowspan="1" colspan="1">5442</td>
<td align="left" rowspan="1" colspan="1">Folic acid + Vitamin B<sub>6</sub>+Vitamin B<sub>12</sub></td>
<td align="left" rowspan="1" colspan="1">Total age-relatedmaculardegeneration<xref ref-type="table-fn" rid="nt104">ii</xref></td>
<td align="left" rowspan="1" colspan="1">Benefit</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Visually significantage-related maculardegeneration<xref ref-type="table-fn" rid="nt103">i</xref></td>
<td align="left" rowspan="1" colspan="1">Benefit</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">CRN</td>
<td align="left" rowspan="1" colspan="1">JAMA, Reuters</td>
<td align="left" rowspan="1" colspan="1">Ebbing 2009 <xref ref-type="bibr" rid="pone.0101533-Ebbing1">[38]</xref></td>
<td align="left" rowspan="1" colspan="1">RCT</td>
<td align="left" rowspan="1" colspan="1">6837</td>
<td align="left" rowspan="1" colspan="1">Folic acid + Vitamin B<sub>12</sub></td>
<td align="left" rowspan="1" colspan="1">Cancer incidence</td>
<td align="left" rowspan="1" colspan="1">Harm</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Cancer mortality</td>
<td align="left" rowspan="1" colspan="1">Harm</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">All-cause mortality</td>
<td align="left" rowspan="1" colspan="1">Harm</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Vitamin B<sub>6</sub></td>
<td align="left" rowspan="1" colspan="1">Cancer incidence</td>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Cancer mortality</td>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">All-cause mortality</td>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">CRN, NPA</td>
<td align="left" rowspan="1" colspan="1">CNN, Health Day</td>
<td align="left" rowspan="1" colspan="1">Ginde 2009 <xref ref-type="bibr" rid="pone.0101533-Ginde1">[39]</xref></td>
<td align="left" rowspan="1" colspan="1">Cross-sectional cohort</td>
<td align="left" rowspan="1" colspan="1">18883</td>
<td align="left" rowspan="1" colspan="1">Vitamin D</td>
<td align="left" rowspan="1" colspan="1">Upper respiratory tract infection</td>
<td align="left" rowspan="1" colspan="1">Benefit</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">ANH</td>
<td align="left" rowspan="1" colspan="1">JNCI, Reuters</td>
<td align="left" rowspan="1" colspan="1">Lin 2009 <xref ref-type="bibr" rid="pone.0101533-Lin2">[40]</xref></td>
<td align="left" rowspan="1" colspan="1">RCT</td>
<td align="left" rowspan="1" colspan="1">7627</td>
<td align="left" rowspan="1" colspan="1">Vitamin C</td>
<td align="left" rowspan="1" colspan="1">Invasive cancer<xref ref-type="table-fn" rid="nt104">ii</xref></td>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Cancer mortality<xref ref-type="table-fn" rid="nt104">ii</xref></td>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Vitamin E</td>
<td align="left" rowspan="1" colspan="1">Invasive cancer<xref ref-type="table-fn" rid="nt104">ii</xref></td>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Cancer mortality<xref ref-type="table-fn" rid="nt104">ii</xref></td>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Beta Carotene</td>
<td align="left" rowspan="1" colspan="1">Invasive cancer<xref ref-type="table-fn" rid="nt104">ii</xref></td>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Cancer mortality<xref ref-type="table-fn" rid="nt104">ii</xref></td>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">CRN, ANH</td>
<td align="left" rowspan="1" colspan="1">JAMA, CNN</td>
<td align="left" rowspan="1" colspan="1">Neuhouser 2009 <xref ref-type="bibr" rid="pone.0101533-Neuhouser1">[41]</xref></td>
<td align="left" rowspan="1" colspan="1">Prospective Cohort</td>
<td align="left" rowspan="1" colspan="1">161808</td>
<td align="left" rowspan="1" colspan="1">Multivitamins</td>
<td align="left" rowspan="1" colspan="1">Cancer</td>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">CV disease</td>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Total mortality</td>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">CRN, ANH</td>
<td align="left" rowspan="1" colspan="1">JAMA, NY Times</td>
<td align="left" rowspan="1" colspan="1">Park 2009 <xref ref-type="bibr" rid="pone.0101533-Park1">[42]</xref></td>
<td align="left" rowspan="1" colspan="1">Prospective Cohort</td>
<td align="left" rowspan="1" colspan="1">492810</td>
<td align="left" rowspan="1" colspan="1">Dairy food intake</td>
<td align="left" rowspan="1" colspan="1">Cancers of thedigestive system</td>
<td align="left" rowspan="1" colspan="1">Benefit</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Calcium intake</td>
<td align="left" rowspan="1" colspan="1">Total cancer</td>
<td align="left" rowspan="1" colspan="1">Benefit</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Cancers of thedigestive system</td>
<td align="left" rowspan="1" colspan="1">Benefit</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">CRN</td>
<td align="left" rowspan="1" colspan="1">JAMA, Reuters</td>
<td align="left" rowspan="1" colspan="1">Snitz 2009 <xref ref-type="bibr" rid="pone.0101533-Snitz1">[43]</xref></td>
<td align="left" rowspan="1" colspan="1">RCT</td>
<td align="left" rowspan="1" colspan="1">3069</td>
<td align="left" rowspan="1" colspan="1">Gingko biloba</td>
<td align="left" rowspan="1" colspan="1">Cognitivefunction</td>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">CRN</td>
<td align="left" rowspan="1" colspan="1">JAMA, Reuters</td>
<td align="left" rowspan="1" colspan="1">Armitage 2010 <xref ref-type="bibr" rid="pone.0101533-Armitage1">[44]</xref></td>
<td align="left" rowspan="1" colspan="1">RCT</td>
<td align="left" rowspan="1" colspan="1">12064</td>
<td align="left" rowspan="1" colspan="1">Folic acid + Vitamin B<sub>12</sub></td>
<td align="left" rowspan="1" colspan="1">First majorvascular event</td>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">CRN</td>
<td align="left" rowspan="1" colspan="1">BMJ, Reuters</td>
<td align="left" rowspan="1" colspan="1">Bolland 2010 <xref ref-type="bibr" rid="pone.0101533-Bolland1">[45]</xref></td>
<td align="left" rowspan="1" colspan="1">Meta-RCT</td>
<td align="left" rowspan="1" colspan="1">11921</td>
<td align="left" rowspan="1" colspan="1">Calcium supplements</td>
<td align="left" rowspan="1" colspan="1">Myocardialinfarction</td>
<td align="left" rowspan="1" colspan="1">Harm</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Stroke</td>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Myocardialinfarction, stroke,or sudden death</td>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">CRN</td>
<td align="left" rowspan="1" colspan="1">JAMA, NY Times</td>
<td align="left" rowspan="1" colspan="1">Makrides 2010 <xref ref-type="bibr" rid="pone.0101533-Makrides1">[46]</xref></td>
<td align="left" rowspan="1" colspan="1">RCT</td>
<td align="left" rowspan="1" colspan="1">Women 2363</td>
<td align="left" rowspan="1" colspan="1">DHA</td>
<td align="left" rowspan="1" colspan="1">Maternaldepression</td>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Children 726</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Infant cognitionand languagedevelopment</td>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">CRN</td>
<td align="left" rowspan="1" colspan="1">JAMA, ABC</td>
<td align="left" rowspan="1" colspan="1">Quinn 2010 <xref ref-type="bibr" rid="pone.0101533-Quinn1">[47]</xref></td>
<td align="left" rowspan="1" colspan="1">RCT</td>
<td align="left" rowspan="1" colspan="1">402</td>
<td align="left" rowspan="1" colspan="1">DHA</td>
<td align="left" rowspan="1" colspan="1">Cognitivefunction</td>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">CRN</td>
<td align="left" rowspan="1" colspan="1">ABC, Reuters</td>
<td align="left" rowspan="1" colspan="1">Wandel 2010 <xref ref-type="bibr" rid="pone.0101533-Wandel1">[48]</xref></td>
<td align="left" rowspan="1" colspan="1">Meta-RCT</td>
<td align="left" rowspan="1" colspan="1">3803</td>
<td align="left" rowspan="1" colspan="1">Chondroitin</td>
<td align="left" rowspan="1" colspan="1">Joint pain</td>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Glucosamine</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Chondroitin + glucosamine</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">CRN</td>
<td align="left" rowspan="1" colspan="1">NCCAM, JAMA</td>
<td align="left" rowspan="1" colspan="1">Barry 2011 <xref ref-type="bibr" rid="pone.0101533-Barry1">[49]</xref></td>
<td align="left" rowspan="1" colspan="1">RCT</td>
<td align="left" rowspan="1" colspan="1">369</td>
<td align="left" rowspan="1" colspan="1">Saw palmetto</td>
<td align="left" rowspan="1" colspan="1">Lower urinarytract symptoms</td>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">CRN</td>
<td align="left" rowspan="1" colspan="1">NCCAM, JAMA</td>
<td align="left" rowspan="1" colspan="1">Klein 2011 <xref ref-type="bibr" rid="pone.0101533-Klein2">[50]</xref></td>
<td align="left" rowspan="1" colspan="1">RCT</td>
<td align="left" rowspan="1" colspan="1">35533</td>
<td align="left" rowspan="1" colspan="1">Selenium</td>
<td align="left" rowspan="1" colspan="1">Prostate cancer</td>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Vitamin E</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Harm</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Selenium + Vitamin E</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">CRN, ANH</td>
<td align="left" rowspan="1" colspan="1">JAMA, Reuters</td>
<td align="left" rowspan="1" colspan="1">Mursu 2011 <xref ref-type="bibr" rid="pone.0101533-Mursu1">[51]</xref></td>
<td align="left" rowspan="1" colspan="1">Prospective cohort</td>
<td align="left" rowspan="1" colspan="1">38772</td>
<td align="left" rowspan="1" colspan="1">Multivitamins</td>
<td align="left" rowspan="1" colspan="1">Mortality</td>
<td align="left" rowspan="1" colspan="1">Harm</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Vitamin B<sub>6</sub></td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Harm</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Folic acid</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Harm</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Iron</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Harm</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Magnesium</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Harm</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Zinc</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Harm</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Copper</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Harm</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Calcium</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Benefit</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">CRN</td>
<td align="left" rowspan="1" colspan="1">Health Day, Reuters</td>
<td align="left" rowspan="1" colspan="1">Bischoff-Ferrari 2012 <xref ref-type="bibr" rid="pone.0101533-BischoffFerrari1">[52]</xref></td>
<td align="left" rowspan="1" colspan="1">Meta-RCT</td>
<td align="left" rowspan="1" colspan="1">31022</td>
<td align="left" rowspan="1" colspan="1">Vitamin D</td>
<td align="left" rowspan="1" colspan="1">Hip fractures</td>
<td align="left" rowspan="1" colspan="1">Benefit<xref ref-type="table-fn" rid="nt107">a</xref></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Non-vertebralfractures</td>
<td align="left" rowspan="1" colspan="1">Benefit<xref ref-type="table-fn" rid="nt107">a</xref></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">CRN</td>
<td align="left" rowspan="1" colspan="1">JAMA, Reuters</td>
<td align="left" rowspan="1" colspan="1">Gaziano 2012 <xref ref-type="bibr" rid="pone.0101533-Gaziano1">[53]</xref></td>
<td align="left" rowspan="1" colspan="1">RCT</td>
<td align="left" rowspan="1" colspan="1">14641</td>
<td align="left" rowspan="1" colspan="1">Multivitamin</td>
<td align="left" rowspan="1" colspan="1">Total cancer</td>
<td align="left" rowspan="1" colspan="1">Benefit</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">CRN</td>
<td align="left" rowspan="1" colspan="1">Health Day, NPR</td>
<td align="left" rowspan="1" colspan="1">Kramer 2012 <xref ref-type="bibr" rid="pone.0101533-Kramer1">[54]</xref></td>
<td align="left" rowspan="1" colspan="1">Prospective Cohort</td>
<td align="left" rowspan="1" colspan="1">15099</td>
<td align="left" rowspan="1" colspan="1">Vitamin D</td>
<td align="left" rowspan="1" colspan="1">All-cause mortality</td>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">CRN, NPA</td>
<td align="left" rowspan="1" colspan="1">ABC, LA Times</td>
<td align="left" rowspan="1" colspan="1">Kwak 2012 <xref ref-type="bibr" rid="pone.0101533-Kwak1">[55]</xref></td>
<td align="left" rowspan="1" colspan="1">Meta-RCT</td>
<td align="left" rowspan="1" colspan="1">20485</td>
<td align="left" rowspan="1" colspan="1">Omega-3 fatty acids</td>
<td align="left" rowspan="1" colspan="1">CV events</td>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">CRN, NPA</td>
<td align="left" rowspan="1" colspan="1">Guardian (UK), Health Day</td>
<td align="left" rowspan="1" colspan="1">Li 2012 <xref ref-type="bibr" rid="pone.0101533-Li1">[56]</xref></td>
<td align="left" rowspan="1" colspan="1">Prospective Cohort</td>
<td align="left" rowspan="1" colspan="1">23980</td>
<td align="left" rowspan="1" colspan="1">Dietary andsupplemental calcium</td>
<td align="left" rowspan="1" colspan="1">Myocardialinfarction</td>
<td align="left" rowspan="1" colspan="1">Harm</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Stroke</td>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">CV mortality</td>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">CRN</td>
<td align="left" rowspan="1" colspan="1">JAMA, Reuters</td>
<td align="left" rowspan="1" colspan="1">Murdoch 2012 <xref ref-type="bibr" rid="pone.0101533-Murdoch1">[57]</xref></td>
<td align="left" rowspan="1" colspan="1">RCT</td>
<td align="left" rowspan="1" colspan="1">322</td>
<td align="left" rowspan="1" colspan="1">Vitamin D</td>
<td align="left" rowspan="1" colspan="1">Upper respiratorytract infection</td>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">CRN</td>
<td align="left" rowspan="1" colspan="1">JAMA, Reuters</td>
<td align="left" rowspan="1" colspan="1">Rizos 2012 <xref ref-type="bibr" rid="pone.0101533-Rizos1">[58]</xref></td>
<td align="left" rowspan="1" colspan="1">Meta-RCT</td>
<td align="left" rowspan="1" colspan="1">68680</td>
<td align="left" rowspan="1" colspan="1">Omega-3 fatty acid</td>
<td align="left" rowspan="1" colspan="1">All-causemortality</td>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Cardiac mortality</td>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Sudden death</td>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Myocardialinfarction</td>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Stroke</td>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">CRN</td>
<td align="left" rowspan="1" colspan="1">JAMA, Reuters</td>
<td align="left" rowspan="1" colspan="1">Sesso 2012 <xref ref-type="bibr" rid="pone.0101533-Sesso2">[59]</xref></td>
<td align="left" rowspan="1" colspan="1">RCT</td>
<td align="left" rowspan="1" colspan="1">14641</td>
<td align="left" rowspan="1" colspan="1">Multivitamin</td>
<td align="left" rowspan="1" colspan="1">Major CVevents</td>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">CRN</td>
<td align="left" rowspan="1" colspan="1">NEI, Reuters</td>
<td align="left" rowspan="1" colspan="1">The AREDS2 Research Group 2013 <xref ref-type="bibr" rid="pone.0101533-Chew1">[60]</xref></td>
<td align="left" rowspan="1" colspan="1">RCT</td>
<td align="left" rowspan="1" colspan="1">4203</td>
<td align="left" rowspan="1" colspan="1">Lutein + zeaxanthin</td>
<td align="left" rowspan="1" colspan="1">Cataract Surgery<xref ref-type="table-fn" rid="nt105">iii</xref></td>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Vision Loss<xref ref-type="table-fn" rid="nt105">iii</xref></td>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">CRN</td>
<td align="left" rowspan="1" colspan="1">NEI, JAMA</td>
<td align="left" rowspan="1" colspan="1">The AREDS2 Research Group 2013 <xref ref-type="bibr" rid="pone.0101533-Chew2">[61]</xref></td>
<td align="left" rowspan="1" colspan="1">RCT</td>
<td align="left" rowspan="1" colspan="1">4203</td>
<td align="left" rowspan="1" colspan="1">Lutein + zeaxanthin</td>
<td align="left" rowspan="1" colspan="1">Maculardegeneration</td>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">DHA +EPA</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Lutein + zeaxanthin +DHA + EPA</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">CRN</td>
<td align="left" rowspan="1" colspan="1">BMJ, Daily Express</td>
<td align="left" rowspan="1" colspan="1">Michaelsson 2013 <xref ref-type="bibr" rid="pone.0101533-Michaelsson1">[62]</xref></td>
<td align="left" rowspan="1" colspan="1">Prospective Cohort</td>
<td align="left" rowspan="1" colspan="1">61433</td>
<td align="left" rowspan="1" colspan="1">Dietary andsupplemental calcium</td>
<td align="left" rowspan="1" colspan="1">All-causemortality</td>
<td align="left" rowspan="1" colspan="1">Harm</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Cause specificCV disease mortality</td>
<td align="left" rowspan="1" colspan="1">Harm</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Ischaemic heartdisease mortality</td>
<td align="left" rowspan="1" colspan="1">Harm</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Stroke mortality</td>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">CRN, NPA</td>
<td align="left" rowspan="1" colspan="1">JAMA, Reuters</td>
<td align="left" rowspan="1" colspan="1">Xiao 2013 <xref ref-type="bibr" rid="pone.0101533-Xiao1">[63]</xref></td>
<td align="left" rowspan="1" colspan="1">Prospective Cohort</td>
<td align="left" rowspan="1" colspan="1">388229</td>
<td align="left" rowspan="1" colspan="1">Dietary andsupplemental calcium</td>
<td align="left" rowspan="1" colspan="1">CV diseasemortality</td>
<td align="left" rowspan="1" colspan="1">Harm<xref ref-type="table-fn" rid="nt106">iv</xref></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Heart diseasemortality</td>
<td align="left" rowspan="1" colspan="1">Harm<xref ref-type="table-fn" rid="nt106">iv</xref></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Cerebrovasculardisease mortality</td>
<td align="left" rowspan="1" colspan="1">No effect</td>
</tr>
</tbody>
</table>
</alternatives><table-wrap-foot><fn id="nt101"><label/><p>RCT, Randomized Controlled Trial; Meta-RCT, Meta-analysis of Randomized Controlled Trials; CV, Cardiovascular; DHA, docosahexanoic acid; EPA, eicosapentanoic acid.</p></fn><fn id="nt102"><label/><p>CRN, Council for Responsible Nutrition; ANH, Alliance for Natural Health; NPA, Natural Products Association; NCCAM, National Centre for Complementary and Alternative Medicine; NHLBI, National Heart, Lung and Blood Institute; NCI, National Cancer Institute; NEI, National Eye Institute; JAMA, JAMA Network; BMJ, British Medical Journal; Cochrane, Cochrane Collaboration; JNCI, Journal of the National Cancer Institute; Reuters, Reuters Health; NY Times, New York Times; ABC, American Broadcasting Company; AP, Associated Press; BBC, British Broadcasting Corporation; CNN, Cable News Network; US News, US News &amp; World Report; CBC, Canadian Broadcasting Corporation; LA Times, Los Angeles Times; NPR, National Public Radio; SF Chronicle, San Francisco Chronicle.</p></fn><fn id="nt103"><label>i</label><p>Source article reports on a secondary outcome. The primary outcome of the study is fractures.</p></fn><fn id="nt104"><label>ii</label><p>Source article reports on secondary outcomes. The primary outcome of the study is cardiovascular disease.</p></fn><fn id="nt105"><label>iii</label><p>Source article reports on secondary outcomes. The primary outcome of the study is advanced age-related macular degeneration.</p></fn><fn id="nt106"><label>iv</label><p>Harm reported in men, no effect was observed for women.</p></fn><fn id="nt107"><label>a</label><p>Treatment-adherence analysis. Intention to treat analyses found no treatment effect on hip fracture and significant reduction in non-vertebral fracture.</p></fn></table-wrap-foot></table-wrap>
<p><xref ref-type="supplementary-material" rid="pone.0101533.s001">Table S1</xref> summarizes the types of studies reported by the source publications, according to study outcomes. Most of the studies (37/46, 80%) were randomized trials or meta-analyses of randomized trials, and most (28/46, 61%) reported no effect of the supplement investigated.</p>
</sec><sec id="s3b">
<title>Non-industry press releases and news stories</title>
<p><xref ref-type="table" rid="pone-0101533-t001">Table 1</xref> contains the sources of the non-industry press releases and news stories. One non-industry media document referred to two source articles. Consequently, there were 91 non-industry press releases and news stories, containing 92 responses to the 46 source publications. 55 (60%) of the non-industry press releases and news stories were from news agencies, 28 (31%) from the journal of publication, and 8 (9%) from the National Institutes of Health (NIH)/National Center for Complementary and Alternative Medicine (NCCAM).</p>
</sec><sec id="s3c">
<title>‘Spin’ analyses</title>
<p>At least 1 item of ‘spin’ was present in all 53 industry media responses, compared to 51/92 (55%) non-industry media responses (P&lt;0.001). The prevalence of hyping ‘spin’ did not differ between industry and non-industry media responses (16/53, 30%, vs 38/92, 41%; P = 0.21) but denigratory spin was more frequent in the industry media responses (40/53, 75% vs 21/92, 23%; P&lt;0.001).</p>
<p>‘Spin’ scores differed by &gt;2 points between reviewers for 19/145 (13%) of media responses, 13/53 industry and 6/92 non-industry. <xref ref-type="fig" rid="pone-0101533-g002">Figure 2a</xref> shows the total ‘spin’ scores in the industry and non-industry media responses. Considering all studies, the ‘spin’ score in the industry media responses (median 6, 95%CI 5.5–6.5) was higher than that in the non-industry media responses (0.5, 0.0–1.0; P&lt;0.001). ‘Spin’ scores were higher in the industry media responses for studies that reported benefit, reported no benefit, or reported harm of the supplement (P&lt;0.001 for each).</p>
<fig id="pone-0101533-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0101533.g002</object-id><label>Figure 2</label><caption>
<title>Total (a), hyping (b) and denigratory (c) ‘spin’ scores of industry and non-industry media responses, according to outcomes of source publications.</title>
<p>Each point represents the ‘spin’ score of an individual media response. Where multiple scores of the same value occur, the number of overlapping ‘spin’ scores is indicated in parentheses to the right of the overlapping values. Bars represent the median and 95% CI.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0101533.g002" position="float" xlink:type="simple"/></fig>
<p>To investigate whether directional ‘spin’ was present, we analyzed the hyping and denigratory ‘spin’ scores according to the outcome of the study (<xref ref-type="fig" rid="pone-0101533-g002">Figures 2b–c</xref>). Considering all studies, hyping ‘spin’ scores were similar between industry and non-industry media responses (P = 0.74). For studies that reported benefit of supplements, hyping ‘spin’ scores were higher in industry media responses (3.3, 1.0–5.5) than in the non-industry media responses (0.5, 0–1.0; P&lt;0.001). Hyping ‘spin’ scores were not different between industry and non-industry media responses for studies that reported no effect (P = 0.57) or harm (P = 0.06). Considering all studies, the denigratory ‘spin’ score was higher in industry media responses (6, 5.0–6.5) than non-industry media responses (0, 0–0; P&lt;0.001). No denigratory ‘spin’ was present in industry media responses to studies reporting benefit of a supplement. Denigratory ‘spin’ scores were significantly higher in industry than non-industry media responses to publication of studies that found no effect (6.0, 5.0–7.0 vs 0, 0–0; P&lt;0.001) or harm (6.0, 5.5–7.5 vs 0, 0–0.5; P&lt;0.001) from a supplement. Removing responses from any of the non-industry sources (journals of publication, NIH, or news agencies) did not change the results of any of these analyses (data not shown).</p>
<p>The frequency of ‘spin’ techniques that were identified in at least 15% of media responses from either industry or non-industry sources is shown in <xref ref-type="supplementary-material" rid="pone.0101533.s002">Table S2</xref>.</p>
</sec><sec id="s3d">
<title>Interpretation of press releases and news stories</title>
<p>There was no instance of assessor disagreement over the disposition of the media documents towards use of supplements. Industry media responses were more likely than non-industry media responses to support use of supplements. Considering all studies, the text of 51/53 (96%, 87–100) industry media responses was supportive of use of the supplement(s), in comparison to 25/92 (27%, 19–37) non-industry media responses (P&lt;0.001) (<xref ref-type="fig" rid="pone-0101533-g003">Figure 3a</xref>). Industry and non-industry media responses were equally supportive of use of the supplement(s) in studies which reported benefit. For studies reporting no effect or harm of a supplement, the text of 97% (83–100) and 93% (66–100), respectively, of industry media responses was supportive of use of the supplement, while 16% (8–28) and 0% (0–17) of non-industry media responses were supportive of use (P&lt;0.001 for each industry vs non-industry comparison). A similar pattern of results was apparent when the titles of media responses were assessed (<xref ref-type="fig" rid="pone-0101533-g003">Figure 3b</xref>).</p>
<fig id="pone-0101533-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0101533.g003</object-id><label>Figure 3</label><caption>
<title>Disposition of industry and non-industry media responses towards use of supplements, according to outcome of source publications.</title>
<p>Data on the bars are the percentage of full text (a) and titles (b) of media responses that are supportive, non-supportive or neutral towards supplement use.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0101533.g003" position="float" xlink:type="simple"/></fig></sec><sec id="s3e">
<title>Reporting of study characteristics and outcomes</title>
<p>Reporting of study design did not differ between industry and non-industry media responses, but industry media responses were less likely than non-industry media responses to report sample size (18/53, 34% vs 88/93, 96%; P&lt;0.001) or to identify study outcomes (33/53, 62% vs 92/92, 100%; P&lt;0.001) (<xref ref-type="table" rid="pone-0101533-t002">Table 2</xref>). Each of these differences was more marked for studies that reported no effect or harm of a supplement. Study outcomes were identified in 8/8 (100%) industry media responses to studies reporting benefit of supplements, but only 19/31 (61%) and 6/14 (43%) of those issued in response to studies reporting no effect or harm, respectively. Study outcomes were reported using relative numbers in 9/53 (17%) of industry media responses and 39/92 (42%) of non-industry media responses (P = 0.002); outcomes were reported using absolute numbers in 0/53 (0%) of industry media responses and 25/92 (27%) of non-industry media responses (P&lt;0.001). A numerical description of the study outcome was present in 7/8 (88%) industry media responses to studies reporting benefit of a supplement, but only 2/31 (6%) and 1/14 (7%) media responses to studies reporting no effect or harm, respectively.</p>
<table-wrap id="pone-0101533-t002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0101533.t002</object-id><label>Table 2</label><caption>
<title>Reporting of study characteristics and outcomes.</title>
</caption><alternatives><graphic id="pone-0101533-t002-2" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0101533.t002" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td colspan="2" align="left" rowspan="1">Reporting of Study Characteristics</td>
<td colspan="3" align="left" rowspan="1">All Studies</td>
<td colspan="2" align="left" rowspan="1">Studies Reporting Benefit</td>
<td colspan="2" align="left" rowspan="1">Studies Reporting No Effect</td>
<td colspan="2" align="left" rowspan="1">Studies Reporting Harm</td>
</tr>
<tr>
<td colspan="2" align="left" rowspan="1"/>
<td colspan="2" align="left" rowspan="1">Industry (n = 53)</td>
<td align="left" rowspan="1" colspan="1">Non-industry (n = 92)</td>
<td align="left" rowspan="1" colspan="1">Industry (n = 8)</td>
<td align="left" rowspan="1" colspan="1">Non-industry (N = 16)</td>
<td align="left" rowspan="1" colspan="1">Industry (n = 31)</td>
<td align="left" rowspan="1" colspan="1">Non-industry (n = 56)</td>
<td align="left" rowspan="1" colspan="1">Industry (n = 14)</td>
<td align="left" rowspan="1" colspan="1">Non-industry (n = 20)</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">Study Design</td>
<td colspan="2" align="left" rowspan="1">n</td>
<td align="left" rowspan="1" colspan="1">24</td>
<td align="left" rowspan="1" colspan="1">54</td>
<td align="left" rowspan="1" colspan="1">6</td>
<td align="left" rowspan="1" colspan="1">9</td>
<td align="left" rowspan="1" colspan="1">10</td>
<td align="left" rowspan="1" colspan="1">36</td>
<td align="left" rowspan="1" colspan="1">8</td>
<td align="left" rowspan="1" colspan="1">9</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="2" align="left" rowspan="1">%</td>
<td align="left" rowspan="1" colspan="1">45 (32–60)</td>
<td align="left" rowspan="1" colspan="1">59 (48–69)</td>
<td align="left" rowspan="1" colspan="1">75 (35–97)</td>
<td align="left" rowspan="1" colspan="1">56 (30–80)</td>
<td align="left" rowspan="1" colspan="1">32 (17–51)</td>
<td align="left" rowspan="1" colspan="1">64 (50–77)</td>
<td align="left" rowspan="1" colspan="1">57 (29–82)</td>
<td align="left" rowspan="1" colspan="1">45 (23–68)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="2" align="left" rowspan="1">P</td>
<td colspan="2" align="left" rowspan="1">0.12</td>
<td colspan="2" align="left" rowspan="1">0.66</td>
<td colspan="2" align="left" rowspan="1">0.007</td>
<td colspan="2" align="left" rowspan="1">0.73</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Sample Size</td>
<td colspan="2" align="left" rowspan="1">n</td>
<td align="left" rowspan="1" colspan="1">18</td>
<td align="left" rowspan="1" colspan="1">88</td>
<td align="left" rowspan="1" colspan="1">6</td>
<td align="left" rowspan="1" colspan="1">15</td>
<td align="left" rowspan="1" colspan="1">12</td>
<td align="left" rowspan="1" colspan="1">54</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">19</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="2" align="left" rowspan="1">%</td>
<td align="left" rowspan="1" colspan="1">34 (22–48)</td>
<td align="left" rowspan="1" colspan="1">96 (89–99)</td>
<td align="left" rowspan="1" colspan="1">75 (35–97)</td>
<td align="left" rowspan="1" colspan="1">94 (70–100)</td>
<td align="left" rowspan="1" colspan="1">39 (22–58)</td>
<td align="left" rowspan="1" colspan="1">96 (88–100)</td>
<td align="left" rowspan="1" colspan="1">0 (0–23)</td>
<td align="left" rowspan="1" colspan="1">95 (75–100)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="2" align="left" rowspan="1">P</td>
<td colspan="2" align="left" rowspan="1">&lt;0.001</td>
<td colspan="2" align="left" rowspan="1">0.25</td>
<td colspan="2" align="left" rowspan="1">&lt;0.001</td>
<td colspan="2" align="left" rowspan="1">&lt;0.001</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Study Outcome<italic>Reported in Words</italic></td>
<td colspan="2" align="left" rowspan="1">n</td>
<td align="left" rowspan="1" colspan="1">33</td>
<td align="left" rowspan="1" colspan="1">92</td>
<td align="left" rowspan="1" colspan="1">8</td>
<td align="left" rowspan="1" colspan="1">16</td>
<td align="left" rowspan="1" colspan="1">19</td>
<td align="left" rowspan="1" colspan="1">56</td>
<td align="left" rowspan="1" colspan="1">6</td>
<td align="left" rowspan="1" colspan="1">20</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="2" align="left" rowspan="1">%</td>
<td align="left" rowspan="1" colspan="1">62 (48–75)</td>
<td align="left" rowspan="1" colspan="1">100 (96–100)</td>
<td align="left" rowspan="1" colspan="1">100 (63–100)</td>
<td align="left" rowspan="1" colspan="1">100 (79–100)</td>
<td align="left" rowspan="1" colspan="1">61 (42–78)</td>
<td align="left" rowspan="1" colspan="1">100 (94–100)</td>
<td align="left" rowspan="1" colspan="1">43 (18–71)</td>
<td align="left" rowspan="1" colspan="1">100 (83–100)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="2" align="left" rowspan="1">P</td>
<td colspan="2" align="left" rowspan="1">&lt;0.001</td>
<td colspan="2" align="left" rowspan="1">&gt;0.99</td>
<td colspan="2" align="left" rowspan="1">&lt;0.001</td>
<td colspan="2" align="left" rowspan="1">&lt;0.001</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>Reported using</italic><italic>Relative Numbers</italic></td>
<td colspan="2" align="left" rowspan="1">n</td>
<td align="left" rowspan="1" colspan="1">9</td>
<td align="left" rowspan="1" colspan="1">39</td>
<td align="left" rowspan="1" colspan="1">7</td>
<td align="left" rowspan="1" colspan="1">15</td>
<td align="left" rowspan="1" colspan="1">2</td>
<td align="left" rowspan="1" colspan="1">13</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">11</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="2" align="left" rowspan="1">%</td>
<td align="left" rowspan="1" colspan="1">17 (8–30)</td>
<td align="left" rowspan="1" colspan="1">42 (32–53)</td>
<td align="left" rowspan="1" colspan="1">88 (47–100)</td>
<td align="left" rowspan="1" colspan="1">94 (70–100)</td>
<td align="left" rowspan="1" colspan="1">6 (1–21)</td>
<td align="left" rowspan="1" colspan="1">23 (13–36)</td>
<td align="left" rowspan="1" colspan="1">0 (0–23)</td>
<td align="left" rowspan="1" colspan="1">55 (32–77)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="2" align="left" rowspan="1">P</td>
<td colspan="2" align="left" rowspan="1">0.002</td>
<td colspan="2" align="left" rowspan="1">&gt;0.99</td>
<td colspan="2" align="left" rowspan="1">0.08</td>
<td colspan="2" align="left" rowspan="1">&lt;0.001</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>Reported using</italic><italic>Absolute Numbers</italic></td>
<td colspan="2" align="left" rowspan="1">n</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">25</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">18</td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1">6</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="2" align="left" rowspan="1">%</td>
<td align="left" rowspan="1" colspan="1">0 (0–7)</td>
<td align="left" rowspan="1" colspan="1">27 (18–37)</td>
<td align="left" rowspan="1" colspan="1">0 (0–37)</td>
<td align="left" rowspan="1" colspan="1">6 (0–30)</td>
<td align="left" rowspan="1" colspan="1">0 (0–11)</td>
<td align="left" rowspan="1" colspan="1">32 (20–46)</td>
<td align="left" rowspan="1" colspan="1">7 (0–34)</td>
<td align="left" rowspan="1" colspan="1">30 (12–54)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="2" align="left" rowspan="1">P</td>
<td colspan="2" align="left" rowspan="1">&lt;0.001</td>
<td colspan="2" align="left" rowspan="1">&gt;0.99</td>
<td colspan="2" align="left" rowspan="1">&lt;0.001</td>
<td colspan="2" align="left" rowspan="1">0.20</td>
</tr>
</tbody>
</table>
</alternatives><table-wrap-foot><fn id="nt108"><label/><p>Data are number of industry and non-industry media responses that reported the indicated study characteristic, or % (95% CI).</p></fn></table-wrap-foot></table-wrap>
<p>Industry media responses were less likely than non-industry media responses to include quotes from study investigators (0/53, 0% vs 84/92, 91%; P&lt;0.001) or other commentators (4/53, 8% vs 59/92, 64%; P&lt;0.001), and more likely to include quotes from industry employees (53/53, 100% vs 10/92, 11%; P&lt;0.001).</p>
</sec><sec id="s3f">
<title>Propagation of industry press releases</title>
<p>On the websites of six organizations that service, inform and advise manufacturers, marketers and retailers of dietary supplements, we identified 148 news stories that directly referenced an industry press release (<xref ref-type="supplementary-material" rid="pone.0101533.s003">Table S3</xref>). The median (range) number of news stories that referenced an industry press release per source publication was 3 (0–10). Industry press releases generated in response to 42/46 (91%) of the source publications were referenced in at least one news story on at least one of the websites.</p>
</sec></sec><sec id="s4">
<title>Discussion</title>
<p>Research on press releases issued by pharmaceutical companies and academic institutions has emphasized their propensity to hype research findings, by reporting positive preliminary data, omitting important study information, failing to discuss caveats and limitations, and exaggerating the importance of the results <xref ref-type="bibr" rid="pone.0101533-Woloshin1">[13]</xref>, <xref ref-type="bibr" rid="pone.0101533-Kuriya1">[64]</xref>. We are unaware of research evaluating press releases from the supplements industry, or examining denigratory ‘spin’. Our analysis suggests that press releases issued by organizations which represent and promote the commercial interests of the manufacturers and retailers of supplemental medicines in response to the publication of clinical research findings about supplements contain more ‘spin’ than press releases and news stories from non-industry sources. Notably, the ‘spin’ in industry press releases strongly favoured use of supplements. More hyping ‘spin’ was present in industry press releases than non-industry media documents generated in response to the small number of studies reporting beneficial effects of supplements. The majority of studies (83%) that prompted industry press releases reported no benefit or harm of the supplement. In response to these studies, industry press releases were enriched for denigratory ‘spin’, and were almost unanimously (&gt;90%) supportive of use of the supplement.</p>
<p>Industry press releases were also less likely than non-industry media documents to report key study characteristics such as sample size and study outcomes. This difference was apparent only for studies which reported no effect or harm of the supplement. Failure to identify and report study outcomes and provide estimates of effect size were common techniques by which industry press releases downplayed the outcomes of studies which failed to demonstrate benefit of supplements. Industry press releases never included interviews with the authors of the source publication, and rarely included opinions on the findings of the source publication from non-industry experts.</p>
<p>Press releases influence news stories <xref ref-type="bibr" rid="pone.0101533-Yavchitz1">[10]</xref>, <xref ref-type="bibr" rid="pone.0101533-Schwartz1">[11]</xref> and news stories influence health behaviors <xref ref-type="bibr" rid="pone.0101533-Schwartz2">[65]</xref>–<xref ref-type="bibr" rid="pone.0101533-Haas1">[67]</xref>. We found evidence for propagation of supplements industry press releases by organizations whose primary function is to inform and advise the manufacturers, marketers and consumers of dietary supplements. It is likely that these news stories influenced the attitudes of retailers and marketers of supplements, and thereby the behaviors of supplements consumers. The news stories may also have directly influenced consumer behaviour. Most supplements users do not take the agents on the advice of a health care professional <xref ref-type="bibr" rid="pone.0101533-Bailey1">[1]</xref>, and many do not discuss supplement use with their doctor <xref ref-type="bibr" rid="pone.0101533-Blendon1">[4]</xref>, <xref ref-type="bibr" rid="pone.0101533-Albertazzi1">[5]</xref>, while information sources such as people other than health professionals, the internet, magazines, and news stories are influential <xref ref-type="bibr" rid="pone.0101533-Bacon1">[2]</xref>, <xref ref-type="bibr" rid="pone.0101533-Albertazzi1">[5]</xref>. It is therefore likely that the propagation of the ‘spin’-enriched industry press releases contributes to the ongoing, and even burgeoning, enthusiasm for use of supplements in the face of accumulating evidence of their ineffectiveness <xref ref-type="bibr" rid="pone.0101533-Bjelakovic1">[6]</xref>, <xref ref-type="bibr" rid="pone.0101533-Rizos1">[58]</xref>, <xref ref-type="bibr" rid="pone.0101533-Clarke1">[68]</xref> and, in some cases, harm <xref ref-type="bibr" rid="pone.0101533-Bjelakovic1">[6]</xref>, <xref ref-type="bibr" rid="pone.0101533-Ebbing1">[38]</xref>. Continued use of interventions which are promoted as having health benefits despite evidence for lack of efficacy may discourage use of interventions for which evidence for efficacy is established <xref ref-type="bibr" rid="pone.0101533-Prasad1">[14]</xref> and can have adverse financial consequences for individual users <xref ref-type="bibr" rid="pone.0101533-Bacon1">[2]</xref>.</p>
<p>Our study has limitations. Although our analyses were of press releases from three prominent supplements industry organizations, the results might not apply to press releases from other industry organizations. Media document content analysis and interpretation were subjective, but were performed independently by two reviewers, with a high level of agreement, and consensus to resolve disagreements. A blinded analysis would be ideal but, because of substantial differences in style and formatting among the sources of media documents, it was not possible to achieve without altering the documents so much that the original structure and tone would be lost. The control set of media documents included news stories and press releases, but sensitivity analyses found similar results after exclusion of the former documents. Analyses of responses to studies reporting benefits of supplements were limited by the small sample size.</p>
<p>Our results suggest that press releases issued by the supplements industry in response to clinical research on its products consistently include ‘spin’ that promotes the use of supplements, regardless of the research findings. Journalists, health practitioners and advisors, and consumers of supplemental medicines should therefore be sceptical of the content of press releases issued by organizations representing the supplements industry in response to clinical studies of supplements, and seek information from non-industry sources where the use of ‘spin’ is less common.</p>
</sec><sec id="s5">
<title>Supporting Information</title>
<supplementary-material id="pone.0101533.s001" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xlink:href="info:doi/10.1371/journal.pone.0101533.s001" position="float" xlink:type="simple"><label>Table S1</label><caption>
<p>Design and outcome of studies that generated industry press releases.</p>
<p>(DOCX)</p>
</caption></supplementary-material><supplementary-material id="pone.0101533.s002" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xlink:href="info:doi/10.1371/journal.pone.0101533.s002" position="float" xlink:type="simple"><label>Table S2</label><caption>
<p>Frequency of the most common ‘spin’ techniques observed in press releases or news stories.</p>
<p>(DOCX)</p>
</caption></supplementary-material><supplementary-material id="pone.0101533.s003" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xlink:href="info:doi/10.1371/journal.pone.0101533.s003" position="float" xlink:type="simple"><label>Table S3</label><caption>
<p>Propagation of industry press releases by organizations that service manufacturers and retailers of supplements.</p>
<p>(DOCX)</p>
</caption></supplementary-material><supplementary-material id="pone.0101533.s004" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xlink:href="info:doi/10.1371/journal.pone.0101533.s004" position="float" xlink:type="simple"><label>Text S1</label><caption>
<p><bold>Data Abstraction Form 1 - Source Publications.</bold></p>
<p>(DOCX)</p>
</caption></supplementary-material><supplementary-material id="pone.0101533.s005" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xlink:href="info:doi/10.1371/journal.pone.0101533.s005" position="float" xlink:type="simple"><label>Text S2</label><caption>
<p><bold>Data Abstraction Form 2 - Press Releases and New Stories.</bold></p>
<p>(DOCX)</p>
</caption></supplementary-material><supplementary-material id="pone.0101533.s006" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xlink:href="info:doi/10.1371/journal.pone.0101533.s006" position="float" xlink:type="simple"><label>Text S3</label><caption>
<p><bold>‘Spin’ assessment.</bold></p>
<p>(DOCX)</p>
</caption></supplementary-material></sec></body>
<back><ref-list>
<title>References</title>
<ref id="pone.0101533-Bailey1"><label>1</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bailey</surname><given-names>Rl</given-names></name>, <name name-style="western"><surname>Gahche</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Miller</surname><given-names>PE</given-names></name>, <name name-style="western"><surname>Thomas</surname><given-names>PR</given-names></name>, <name name-style="western"><surname>Dwyer</surname><given-names>JT</given-names></name> (<year>2013</year>) <article-title>Why US adults use dietary supplements</article-title>. <source>JAMA Intern Med</source> <volume>173</volume>: <fpage>355</fpage>–<lpage>361</lpage>.</mixed-citation>
</ref>
<ref id="pone.0101533-Bacon1"><label>2</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bacon</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Bolland</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Ames</surname><given-names>RW</given-names></name>, <name name-style="western"><surname>Siu</surname><given-names>ATY</given-names></name>, <name name-style="western"><surname>Mason</surname><given-names>BH</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Prevalent dietary supplement use in older New Zealand men</article-title>. <source>NZ Med J</source> <volume>124</volume>: <fpage>55</fpage>–<lpage>62</lpage>.</mixed-citation>
</ref>
<ref id="pone.0101533-Denison1"><label>3</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Denison</surname><given-names>HJ</given-names></name>, <name name-style="western"><surname>Jameson</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>Syddall</surname><given-names>HE</given-names></name>, <name name-style="western"><surname>Dennison</surname><given-names>EM</given-names></name>, <name name-style="western"><surname>Cooper</surname><given-names>C</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Patterns of dietary supplement use among older men and women in the UK: findings from the Hertfordshire Cohort Study</article-title>. <source>J Nutr Health Aging</source> <volume>16</volume>: <fpage>307</fpage>–<lpage>311</lpage>.</mixed-citation>
</ref>
<ref id="pone.0101533-Blendon1"><label>4</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Blendon</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Benson</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Botta</surname><given-names>MD</given-names></name>, <name name-style="western"><surname>Weldon</surname><given-names>KJ</given-names></name> (<year>2013</year>) <article-title>Users’ views of dietary supplements</article-title>. <source>Arch Intern Med</source> <volume>173</volume>: <fpage>74</fpage>–<lpage>75</lpage>.</mixed-citation>
</ref>
<ref id="pone.0101533-Albertazzi1"><label>5</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Albertazzi</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Steel</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Clifford</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Bottazzi</surname><given-names>M</given-names></name> (<year>2002</year>) <article-title>Attitudes towards and use of dietary supplementation in a sample of postmenopausal women</article-title>. <source>Climacteric</source> <volume>5</volume>: <fpage>374</fpage>–<lpage>382</lpage>.</mixed-citation>
</ref>
<ref id="pone.0101533-Bjelakovic1"><label>6</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bjelakovic</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Nikolova</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Gluud</surname><given-names>C</given-names></name> (<year>2013</year>) <article-title>Antioxidant supplements to prevent mortality</article-title>. <source>JAMA</source> <volume>310</volume>: <fpage>1178</fpage>–<lpage>1179</lpage>.</mixed-citation>
</ref>
<ref id="pone.0101533-The1"><label>7</label>
<mixed-citation publication-type="journal" xlink:type="simple"><collab xlink:type="simple">The DIPART Group</collab> (<year>2010</year>) <article-title>Patient level pooled analysis of 68 500 patients from seven major vitamin D fracture trials in US and Europe</article-title>. <source>BMJ</source> <volume>340</volume>: <fpage>b5463</fpage>.</mixed-citation>
</ref>
<ref id="pone.0101533-Klein1"><label>8</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Klein</surname><given-names>EA</given-names></name>, <name name-style="western"><surname>Thompson</surname><given-names>IM</given-names></name>, <name name-style="western"><surname>Tangen</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Crowley</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Lucia</surname><given-names>MS</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Vitamin E and the risk of prostate cancer</article-title>. <source>Journal of the American Medical Association</source> <volume>306</volume>: <fpage>1549</fpage>–<lpage>1556</lpage>.</mixed-citation>
</ref>
<ref id="pone.0101533-Grey1"><label>9</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Grey</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Bolland</surname><given-names>M</given-names></name> (<year>2014</year>) <article-title>Clinical trial evidence and use of fish oil supplements</article-title>. <source>JAMA Intern Med</source> <volume>174</volume>: <fpage>460</fpage>–<lpage>462</lpage>.</mixed-citation>
</ref>
<ref id="pone.0101533-Yavchitz1"><label>10</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yavchitz</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Boutron</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Bafeta</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Marroun</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Charles</surname><given-names>P</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Misrepresentation of randomized controlled trials in press releases and news coverage: a cohort study</article-title>. <source>PLoS Med</source> <volume>9</volume>: <fpage>e1001308</fpage>.</mixed-citation>
</ref>
<ref id="pone.0101533-Schwartz1"><label>11</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Schwartz</surname><given-names>LM</given-names></name>, <name name-style="western"><surname>Woloshin</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Andrews</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Stukel</surname><given-names>TA</given-names></name> (<year>2012</year>) <article-title>Influence of medical journal press releases on the quality of associated newspaper coverage: retrospective cohort study</article-title>. <source>BMJ</source> <volume>344</volume>: <fpage>d8164</fpage>.</mixed-citation>
</ref>
<ref id="pone.0101533-Boutron1"><label>12</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Boutron</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Dutton</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ravaud</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Altman</surname><given-names>DG</given-names></name> (<year>2010</year>) <article-title>Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes</article-title>. <source>JAMA</source> <volume>303</volume>: <fpage>2058</fpage>–<lpage>2064</lpage>.</mixed-citation>
</ref>
<ref id="pone.0101533-Woloshin1"><label>13</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Woloshin</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Schwartz</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Casella</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Kennedy</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Larson</surname><given-names>R</given-names></name> (<year>2009</year>) <article-title>Press releases by academic medical centers: not so academic?</article-title> <source>Ann Intern Med</source> <volume>150</volume>: <fpage>613</fpage>–<lpage>618</lpage>.</mixed-citation>
</ref>
<ref id="pone.0101533-Prasad1"><label>14</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Prasad</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Cifu</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Ioannidis</surname><given-names>JPA</given-names></name> (<year>2012</year>) <article-title>Reversals of established medical practices: evidence to abandon ship</article-title>. <source>JAMA</source> <volume>307</volume>: <fpage>37</fpage>–<lpage>38</lpage>.</mixed-citation>
</ref>
<ref id="pone.0101533-Tatsioni1"><label>15</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tatsioni</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Bonitsis</surname><given-names>NG</given-names></name>, <name name-style="western"><surname>Ioannidis</surname><given-names>JA</given-names></name> (<year>2007</year>) <article-title>Persistence of contradicted claims in the literature</article-title>. <source>JAMA</source> <volume>298</volume>: <fpage>2517</fpage>–<lpage>2526</lpage>.</mixed-citation>
</ref>
<ref id="pone.0101533-deVet1"><label>16</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>de Vet</surname><given-names>HC</given-names></name>, <name name-style="western"><surname>Mokkink</surname><given-names>LB</given-names></name>, <name name-style="western"><surname>Terwee</surname><given-names>CB</given-names></name>, <name name-style="western"><surname>Hoekstra</surname><given-names>OS</given-names></name>, <name name-style="western"><surname>Knol</surname><given-names>DL</given-names></name> (<year>2013</year>) <article-title>Clinicians are right not to like Cohen’s κ</article-title>. <source>BMJ</source> <volume>346</volume>: <fpage>f2125</fpage>.</mixed-citation>
</ref>
<ref id="pone.0101533-Landis1"><label>17</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Landis</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Koch</surname><given-names>GG</given-names></name> (<year>1977</year>) <article-title>The measurement of observer agreement for categorical data</article-title>. <source>Biometrics</source> <volume>33</volume>: <fpage>159</fpage>–<lpage>174</lpage>.</mixed-citation>
</ref>
<ref id="pone.0101533-Lee1"><label>18</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lee</surname><given-names>IM</given-names></name>, <name name-style="western"><surname>Cook</surname><given-names>NR</given-names></name>, <name name-style="western"><surname>Gaziano</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Gordon</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Ridker</surname><given-names>PM</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women’s Health Study: a randomized controlled trial</article-title>. <source>JAMA</source> <volume>294</volume>: <fpage>56</fpage>–<lpage>65</lpage>.</mixed-citation>
</ref>
<ref id="pone.0101533-Lonn1"><label>19</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lonn</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Bosch</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Yusuf</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Sheridan</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Pogue</surname><given-names>J</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial</article-title>. <source>JAMA</source> <volume>293</volume>: <fpage>1338</fpage>–<lpage>1347</lpage>.</mixed-citation>
</ref>
<ref id="pone.0101533-Miller1"><label>20</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Miller</surname><given-names>ER</given-names><suffix>3rd</suffix></name>, <name name-style="western"><surname>Pastor-Barriuso</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Dalal</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Riemersma</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Appel</surname><given-names>LJ</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality</article-title>. <source>Ann Intern Med</source> <volume>142</volume>: <fpage>37</fpage>–<lpage>46</lpage>.</mixed-citation>
</ref>
<ref id="pone.0101533-Bent1"><label>21</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bent</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Kane</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Shinohara</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Neuhaus</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Hudes</surname><given-names>ES</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>Saw palmetto for benign prostatic hyperplasia</article-title>. <source>N Engl J Med</source> <volume>354</volume>: <fpage>557</fpage>–<lpage>566</lpage>.</mixed-citation>
</ref>
<ref id="pone.0101533-Bonaa1"><label>22</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bonaa</surname><given-names>KH</given-names></name>, <name name-style="western"><surname>Njolstad</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Ueland</surname><given-names>PM</given-names></name>, <name name-style="western"><surname>Schirmer</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Tverdal</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>Homocysteine lowering and cardiovascular events after acute myocardial infarction</article-title>. <source>N Engl J Med</source> <volume>354</volume>: <fpage>1578</fpage>–<lpage>1588</lpage>.</mixed-citation>
</ref>
<ref id="pone.0101533-Clegg1"><label>23</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Clegg</surname><given-names>DO</given-names></name>, <name name-style="western"><surname>Reda</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Harris</surname><given-names>CL</given-names></name>, <name name-style="western"><surname>Klein</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>O’Dell</surname><given-names>JR</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis</article-title>. <source>N Engl J Med</source> <volume>354</volume>: <fpage>795</fpage>–<lpage>808</lpage>.</mixed-citation>
</ref>
<ref id="pone.0101533-Jackson1"><label>24</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jackson</surname><given-names>RD</given-names></name>, <name name-style="western"><surname>LaCroix</surname><given-names>AZ</given-names></name>, <name name-style="western"><surname>Gass</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Wallace</surname><given-names>RB</given-names></name>, <name name-style="western"><surname>Robbins</surname><given-names>J</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>Calcium plus vitamin D supplementation and the risk of fractures</article-title>. <source>N Engl J Med</source> <volume>354</volume>: <fpage>669</fpage>–<lpage>683</lpage>.</mixed-citation>
</ref>
<ref id="pone.0101533-Lonn2"><label>25</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lonn</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Yusuf</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Arnold</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Sheridan</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Pogue</surname><given-names>J</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>Homocysteine lowering with folic acid and B vitamins in vascular disease</article-title>. <source>N Engl J Med</source> <volume>354</volume>: <fpage>1567</fpage>–<lpage>1577</lpage>.</mixed-citation>
</ref>
<ref id="pone.0101533-Prince1"><label>26</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Prince</surname><given-names>RL</given-names></name>, <name name-style="western"><surname>Devine</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Dhaliwal</surname><given-names>SS</given-names></name>, <name name-style="western"><surname>Dick</surname><given-names>IM</given-names></name> (<year>2006</year>) <article-title>Effects of calcium supplementation on clinical fracture and bone structure: results of a 5-year, double-blind, placebo-controlled trial in elderly women</article-title>. <source>Arch Intern Med</source> <volume>166</volume>: <fpage>869</fpage>–<lpage>875</lpage>.</mixed-citation>
</ref>
<ref id="pone.0101533-WactawskiWende1"><label>27</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wactawski-Wende</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Kotchen</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Anderson</surname><given-names>GL</given-names></name>, <name name-style="western"><surname>Assaf</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>Brunner</surname><given-names>RL</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>Calcium plus vitamin D supplementation and the risk of colorectal cancer</article-title>. <source>N Engl J Med</source> <volume>354</volume>: <fpage>684</fpage>–<lpage>696</lpage>.</mixed-citation>
</ref>
<ref id="pone.0101533-Bjelakovic2"><label>28</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bjelakovic</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Nikolova</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Gluud</surname><given-names>LL</given-names></name>, <name name-style="western"><surname>Simonetti</surname><given-names>RG</given-names></name>, <name name-style="western"><surname>Gluud</surname><given-names>C</given-names></name> (<year>2007</year>) <article-title>Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis</article-title>. <source>JAMA</source> <volume>297</volume>: <fpage>842</fpage>–<lpage>857</lpage>.</mixed-citation>
</ref>
<ref id="pone.0101533-Cole1"><label>29</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cole</surname><given-names>BF</given-names></name>, <name name-style="western"><surname>Baron</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Sandler</surname><given-names>RS</given-names></name>, <name name-style="western"><surname>Haile</surname><given-names>RW</given-names></name>, <name name-style="western"><surname>Ahnen</surname><given-names>DJ</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>Folic acid for the prevention of colorectal adenomas: a randomized clinical trial</article-title>. <source>JAMA</source> <volume>297</volume>: <fpage>2351</fpage>–<lpage>2359</lpage>.</mixed-citation>
</ref>
<ref id="pone.0101533-Lappe1"><label>30</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lappe</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Travers-Gustafson</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Davies</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>Recker</surname><given-names>RR</given-names></name>, <name name-style="western"><surname>Heaney</surname><given-names>RP</given-names></name> (<year>2007</year>) <article-title>Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial</article-title>. <source>Am J Clin Nutr</source> <volume>85</volume>: <fpage>1586</fpage>–<lpage>1591</lpage>.</mixed-citation>
</ref>
<ref id="pone.0101533-Lin1"><label>31</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lin</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Manson</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>IM</given-names></name>, <name name-style="western"><surname>Cook</surname><given-names>NR</given-names></name>, <name name-style="western"><surname>Buring</surname><given-names>JE</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>Intakes of calcium and vitamin D and breast cancer risk in women</article-title>. <source>Arch Intern Med</source> <volume>167</volume>: <fpage>1050</fpage>–<lpage>1059</lpage>.</mixed-citation>
</ref>
<ref id="pone.0101533-Reichenbach1"><label>32</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Reichenbach</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Sterchi</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Scherer</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Trelle</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Burgi</surname><given-names>E</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>Meta-analysis: chondroitin for osteoarthritis of the knee or hip</article-title>. <source>Ann Intern Med</source> <volume>146</volume>: <fpage>580</fpage>–<lpage>590</lpage>.</mixed-citation>
</ref>
<ref id="pone.0101533-Shah1"><label>33</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Shah</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Sander</surname><given-names>S</given-names></name>, <name name-style="western"><surname>White</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Rinaldi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Coleman</surname><given-names>CI</given-names></name> (<year>2007</year>) <article-title>Evaluation of echinacea for the prevention and treatment of the common cold: a meta-analysis</article-title>. <source>Lancet Infect Dis</source> <volume>7</volume>: <fpage>473</fpage>–<lpage>480</lpage>.</mixed-citation>
</ref>
<ref id="pone.0101533-Bjelakovic3"><label>34</label>
<mixed-citation publication-type="other" xlink:type="simple">Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C (2008) Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst Rev: CD007176.</mixed-citation>
</ref>
<ref id="pone.0101533-Sawitzke1"><label>35</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sawitzke</surname><given-names>AD</given-names></name>, <name name-style="western"><surname>Shi</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Finco</surname><given-names>MF</given-names></name>, <name name-style="western"><surname>Dunlop</surname><given-names>DD</given-names></name>, <name name-style="western"><surname>Bingham</surname><given-names>CO</given-names><suffix>3rd</suffix></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>The effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoarthritis: a report from the Glucosamine/chondroitin Arthritis Intervention Trial</article-title>. <source>Arthritis Rheum</source> <volume>58</volume>: <fpage>3183</fpage>–<lpage>3191</lpage>.</mixed-citation>
</ref>
<ref id="pone.0101533-Sesso1"><label>36</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sesso</surname><given-names>HD</given-names></name>, <name name-style="western"><surname>Buring</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Christen</surname><given-names>WG</given-names></name>, <name name-style="western"><surname>Kurth</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Belanger</surname><given-names>C</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians’ Health Study II randomized controlled trial</article-title>. <source>JAMA</source> <volume>300</volume>: <fpage>2123</fpage>–<lpage>2133</lpage>.</mixed-citation>
</ref>
<ref id="pone.0101533-Christen1"><label>37</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Christen</surname><given-names>WG</given-names></name>, <name name-style="western"><surname>Glynn</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Chew</surname><given-names>EY</given-names></name>, <name name-style="western"><surname>Albert</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Manson</surname><given-names>JE</given-names></name> (<year>2009</year>) <article-title>Folic acid, pyridoxine, and cyanocobalamin combination treatment and age-related macular degeneration in women: the Women’s Antioxidant and Folic Acid Cardiovascular Study</article-title>. <source>Arch Intern Med</source> <volume>169</volume>: <fpage>335</fpage>–<lpage>341</lpage>.</mixed-citation>
</ref>
<ref id="pone.0101533-Ebbing1"><label>38</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ebbing</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Bonaa</surname><given-names>KH</given-names></name>, <name name-style="western"><surname>Nygard</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Arnesen</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Ueland</surname><given-names>PM</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Cancer incidence and mortality after treatment with folic acid and vitamin B12</article-title>. <source>JAMA</source> <volume>302</volume>: <fpage>2119</fpage>–<lpage>2126</lpage>.</mixed-citation>
</ref>
<ref id="pone.0101533-Ginde1"><label>39</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ginde</surname><given-names>AA</given-names></name>, <name name-style="western"><surname>Mansbach</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Camargo</surname><given-names>CA</given-names><suffix>Jr</suffix></name> (<year>2009</year>) <article-title>Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey</article-title>. <source>Arch Intern Med</source> <volume>169</volume>: <fpage>384</fpage>–<lpage>390</lpage>.</mixed-citation>
</ref>
<ref id="pone.0101533-Lin2"><label>40</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lin</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Cook</surname><given-names>NR</given-names></name>, <name name-style="western"><surname>Albert</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Zaharris</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Gaziano</surname><given-names>JM</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Vitamins C and E and beta carotene supplementation and cancer risk: a randomized controlled trial</article-title>. <source>J Natl Cancer Inst</source> <volume>101</volume>: <fpage>14</fpage>–<lpage>23</lpage>.</mixed-citation>
</ref>
<ref id="pone.0101533-Neuhouser1"><label>41</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Neuhouser</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Wassertheil-Smoller</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Thomson</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Aragaki</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Anderson</surname><given-names>GL</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Multivitamin use and risk of cancer and cardiovascular disease in the Women’s Health Initiative cohorts</article-title>. <source>Arch Intern Med</source> <volume>169</volume>: <fpage>294</fpage>–<lpage>304</lpage>.</mixed-citation>
</ref>
<ref id="pone.0101533-Park1"><label>42</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Park</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Leitzmann</surname><given-names>MF</given-names></name>, <name name-style="western"><surname>Subar</surname><given-names>AF</given-names></name>, <name name-style="western"><surname>Hollenbeck</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Schatzkin</surname><given-names>A</given-names></name> (<year>2009</year>) <article-title>Dairy food, calcium, and risk of cancer in the NIH-AARP Diet and Health Study</article-title>. <source>Arch Intern Med</source> <volume>169</volume>: <fpage>391</fpage>–<lpage>401</lpage>.</mixed-citation>
</ref>
<ref id="pone.0101533-Snitz1"><label>43</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Snitz</surname><given-names>BE</given-names></name>, <name name-style="western"><surname>O’Meara</surname><given-names>ES</given-names></name>, <name name-style="western"><surname>Carlson</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Arnold</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Ives</surname><given-names>DG</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial</article-title>. <source>JAMA</source> <volume>302</volume>: <fpage>2663</fpage>–<lpage>2670</lpage>.</mixed-citation>
</ref>
<ref id="pone.0101533-Armitage1"><label>44</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Armitage</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Bowman</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Clarke</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Wallendszus</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Bulbulia</surname><given-names>R</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial</article-title>. <source>JAMA</source> <volume>303</volume>: <fpage>2486</fpage>–<lpage>2494</lpage>.</mixed-citation>
</ref>
<ref id="pone.0101533-Bolland1"><label>45</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bolland</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Avenell</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Baron</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Grey</surname><given-names>A</given-names></name>, <name name-style="western"><surname>MacLennan</surname><given-names>GS</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis</article-title>. <source>BMJ</source> <volume>341</volume>: <fpage>c3691</fpage>.</mixed-citation>
</ref>
<ref id="pone.0101533-Makrides1"><label>46</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Makrides</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Gibson</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>McPhee</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Yelland</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Quinlivan</surname><given-names>J</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial</article-title>. <source>JAMA</source> <volume>304</volume>: <fpage>1675</fpage>–<lpage>1683</lpage>.</mixed-citation>
</ref>
<ref id="pone.0101533-Quinn1"><label>47</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Quinn</surname><given-names>JF</given-names></name>, <name name-style="western"><surname>Raman</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Thomas</surname><given-names>RG</given-names></name>, <name name-style="western"><surname>Yurko-Mauro</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Nelson</surname><given-names>EB</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial</article-title>. <source>JAMA</source> <volume>304</volume>: <fpage>1903</fpage>–<lpage>1911</lpage>.</mixed-citation>
</ref>
<ref id="pone.0101533-Wandel1"><label>48</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wandel</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Juni</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Tendal</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Nuesch</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Villiger</surname><given-names>PM</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis</article-title>. <source>BMJ</source> <volume>341</volume>: <fpage>c4675</fpage>.</mixed-citation>
</ref>
<ref id="pone.0101533-Barry1"><label>49</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Barry</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Meleth</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>JY</given-names></name>, <name name-style="western"><surname>Kreder</surname><given-names>KJ</given-names></name>, <name name-style="western"><surname>Avins</surname><given-names>AL</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Effect of increasing doses of saw palmetto extract on lower urinary tract symptoms: a randomized trial</article-title>. <source>JAMA</source> <volume>306</volume>: <fpage>1344</fpage>–<lpage>1351</lpage>.</mixed-citation>
</ref>
<ref id="pone.0101533-Klein2"><label>50</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Klein</surname><given-names>EA</given-names></name>, <name name-style="western"><surname>Thompson</surname><given-names>IM</given-names><suffix>Jr</suffix></name>, <name name-style="western"><surname>Tangen</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Crowley</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Lucia</surname><given-names>MS</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)</article-title>. <source>JAMA</source> <volume>306</volume>: <fpage>1549</fpage>–<lpage>1556</lpage>.</mixed-citation>
</ref>
<ref id="pone.0101533-Mursu1"><label>51</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mursu</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Robien</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Harnack</surname><given-names>LJ</given-names></name>, <name name-style="western"><surname>Park</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Jacobs</surname><given-names>DR</given-names><suffix>Jr</suffix></name> (<year>2011</year>) <article-title>Dietary supplements and mortality rate in older women: the Iowa Women’s Health Study</article-title>. <source>Arch Intern Med</source> <volume>171</volume>: <fpage>1625</fpage>–<lpage>1633</lpage>.</mixed-citation>
</ref>
<ref id="pone.0101533-BischoffFerrari1"><label>52</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bischoff-Ferrari</surname><given-names>HA</given-names></name>, <name name-style="western"><surname>Willett</surname><given-names>WC</given-names></name>, <name name-style="western"><surname>Orav</surname><given-names>EJ</given-names></name>, <name name-style="western"><surname>Lips</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Meunier</surname><given-names>PJ</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>A pooled analysis of vitamin D dose requirements for fracture prevention</article-title>. <source>N Engl J Med</source> <volume>367</volume>: <fpage>40</fpage>–<lpage>49</lpage>.</mixed-citation>
</ref>
<ref id="pone.0101533-Gaziano1"><label>53</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gaziano</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Sesso</surname><given-names>HD</given-names></name>, <name name-style="western"><surname>Christen</surname><given-names>WG</given-names></name>, <name name-style="western"><surname>Bubes</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>JP</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Multivitamins in the prevention of cancer in men: the Physicians’ Health Study II randomized controlled trial</article-title>. <source>JAMA</source> <volume>308</volume>: <fpage>1871</fpage>–<lpage>1880</lpage>.</mixed-citation>
</ref>
<ref id="pone.0101533-Kramer1"><label>54</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kramer</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Sempos</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Cao</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Luke</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Shoham</surname><given-names>D</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Mortality rates across 25-hydroxyvitamin D (25[OH]D) levels among adults with and without estimated glomerular filtration rate &lt;60 ml/min/1.73 m2: the third national health and nutrition examination survey</article-title>. <source>PLoS One</source> <volume>7</volume>: <fpage>e47458</fpage>.</mixed-citation>
</ref>
<ref id="pone.0101533-Kwak1"><label>55</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kwak</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Myung</surname><given-names>SK</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>YJ</given-names></name>, <name name-style="western"><surname>Seo</surname><given-names>HG</given-names></name> (<year>2012</year>) <article-title>Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials</article-title>. <source>Arch Intern Med</source> <volume>172</volume>: <fpage>686</fpage>–<lpage>694</lpage>.</mixed-citation>
</ref>
<ref id="pone.0101533-Li1"><label>56</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Li</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Kaaks</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Linseisen</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Rohrmann</surname><given-names>S</given-names></name> (<year>2012</year>) <article-title>Associations of dietary calcium intake and calcium supplementation with myocardial infarction and stroke risk and overall cardiovascular mortality in the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition study (EPIC-Heidelberg)</article-title>. <source>Heart</source> <volume>98</volume>: <fpage>920</fpage>–<lpage>925</lpage>.</mixed-citation>
</ref>
<ref id="pone.0101533-Murdoch1"><label>57</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Murdoch</surname><given-names>DR</given-names></name>, <name name-style="western"><surname>Slow</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Chambers</surname><given-names>ST</given-names></name>, <name name-style="western"><surname>Jennings</surname><given-names>LC</given-names></name>, <name name-style="western"><surname>Stewart</surname><given-names>AW</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Effect of vitamin D3 supplementation on upper respiratory tract infections in healthy adults: the VIDARIS randomized controlled trial</article-title>. <source>JAMA</source> <volume>308</volume>: <fpage>1333</fpage>–<lpage>1339</lpage>.</mixed-citation>
</ref>
<ref id="pone.0101533-Rizos1"><label>58</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rizos</surname><given-names>EC</given-names></name>, <name name-style="western"><surname>Ntzani</surname><given-names>EE</given-names></name>, <name name-style="western"><surname>Bika</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Kostapanos</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Elisaf</surname><given-names>MS</given-names></name> (<year>2012</year>) <article-title>Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis</article-title>. <source>JAMA</source> <volume>308</volume>: <fpage>1024</fpage>–<lpage>1033</lpage>.</mixed-citation>
</ref>
<ref id="pone.0101533-Sesso2"><label>59</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sesso</surname><given-names>HD</given-names></name>, <name name-style="western"><surname>Christen</surname><given-names>WG</given-names></name>, <name name-style="western"><surname>Bubes</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>MacFadyen</surname><given-names>J</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Multivitamins in the prevention of cardiovascular disease in men: the Physicians’ Health Study II randomized controlled trial</article-title>. <source>JAMA</source> <volume>308</volume>: <fpage>1751</fpage>–<lpage>1760</lpage>.</mixed-citation>
</ref>
<ref id="pone.0101533-Chew1"><label>60</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chew</surname><given-names>EY</given-names></name> (<year>2013</year>) <article-title>Lutein/Zeaxanthin for the Treatment of Age-Related Cataract: AREDS2 Randomized Trial Report No. 4</article-title>. <source>JAMA Ophthalmol</source>: <fpage>1</fpage>–<lpage>7</lpage>.</mixed-citation>
</ref>
<ref id="pone.0101533-Chew2"><label>61</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chew</surname><given-names>EY</given-names></name> (<year>2013</year>) <article-title>Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial</article-title>. <source>JAMA</source> <volume>309</volume>: <fpage>2005</fpage>–<lpage>2015</lpage>.</mixed-citation>
</ref>
<ref id="pone.0101533-Michaelsson1"><label>62</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Michaelsson</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Melhus</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Warensjo Lemming</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Wolk</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Byberg</surname><given-names>L</given-names></name> (<year>2013</year>) <article-title>Long term calcium intake and rates of all cause and cardiovascular mortality: community based prospective longitudinal cohort study</article-title>. <source>BMJ</source> <volume>346</volume>: <fpage>f228</fpage>.</mixed-citation>
</ref>
<ref id="pone.0101533-Xiao1"><label>63</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Xiao</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Murphy</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Houston</surname><given-names>DK</given-names></name>, <name name-style="western"><surname>Harris</surname><given-names>TB</given-names></name>, <name name-style="western"><surname>Chow</surname><given-names>WH</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Dietary and Supplemental Calcium Intake and Cardiovascular Disease Mortality: The National Institutes of Health-AARP Diet and Health Study</article-title>. <source>JAMA Intern Med</source> <volume>173</volume>: <fpage>639</fpage>–<lpage>646</lpage>.</mixed-citation>
</ref>
<ref id="pone.0101533-Kuriya1"><label>64</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kuriya</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Schneid</surname><given-names>EC</given-names></name>, <name name-style="western"><surname>Bell</surname><given-names>CM</given-names></name> (<year>2008</year>) <article-title>Quality of pharmaceutical industry press releases based on original research</article-title>. <source>PLoS ONE</source> <volume>3</volume>: <fpage>e2828</fpage>.</mixed-citation>
</ref>
<ref id="pone.0101533-Schwartz2"><label>65</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Schwartz</surname><given-names>LM</given-names></name>, <name name-style="western"><surname>Woloshin</surname><given-names>S</given-names></name> (<year>2004</year>) <article-title>The media matter: a call for straightforward medical reporting</article-title>. <source>Ann Intern Med</source> <volume>140</volume>: <fpage>226</fpage>–<lpage>228</lpage>.</mixed-citation>
</ref>
<ref id="pone.0101533-Grilli1"><label>66</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Grilli</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Ramsay</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Minozzi</surname><given-names>S</given-names></name> (<year>2002</year>) <article-title>Mass media interventions: effects on health services utilisation</article-title>. <source>Cochrane Database Syst Rev</source> <comment>CD000389</comment></mixed-citation>
</ref>
<ref id="pone.0101533-Haas1"><label>67</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Haas</surname><given-names>JS</given-names></name>, <name name-style="western"><surname>Kaplan</surname><given-names>CP</given-names></name>, <name name-style="western"><surname>Gerstenberger</surname><given-names>EP</given-names></name>, <name name-style="western"><surname>Kerlikowske</surname><given-names>K</given-names></name> (<year>2004</year>) <article-title>Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results</article-title>. <source>Ann Intern Med</source> <volume>140</volume>: <fpage>184</fpage>–<lpage>188</lpage>.</mixed-citation>
</ref>
<ref id="pone.0101533-Clarke1"><label>68</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Clarke</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Halsey</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Lewington</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Armitage</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Manson</surname><given-names>JE</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals</article-title>. <source>Arch Intern Med</source> <volume>170</volume>: <fpage>1622</fpage>–<lpage>1631</lpage>.</mixed-citation>
</ref>
</ref-list></back>
</article>